Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	SMG1 NTRK3 RPS6KB1 ROR1 ADCK1 INSR STYK1 BAZ1B HKDC1 OAS3 RET TRRAP MAP3K3 POLR3A POLR1D CSNK1G3 PRKAA2 SYK MAST1 PRKDC PIPSL MAPK10 TENT5D IPMK	1.96e-08	938	136	24	GO:0016772
GeneOntologyMolecularFunction	kinase activity	SMG1 NTRK3 RPS6KB1 ROR1 ADCK1 INSR STYK1 BAZ1B HKDC1 RET TRRAP MAP3K3 CSNK1G3 PRKAA2 SYK MAST1 PRKDC PIPSL MAPK10 IPMK	2.40e-07	764	136	20	GO:0016301
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	SMG1 NTRK3 RPS6KB1 ROR1 ADCK1 INSR STYK1 BAZ1B HKDC1 RET MAP3K3 CSNK1G3 PRKAA2 SYK MAST1 PRKDC PIPSL MAPK10 IPMK	3.47e-07	709	136	19	GO:0016773
GeneOntologyMolecularFunction	protein kinase activity	SMG1 NTRK3 RPS6KB1 ROR1 ADCK1 INSR STYK1 BAZ1B RET MAP3K3 CSNK1G3 PRKAA2 SYK MAST1 PRKDC MAPK10	3.37e-06	600	136	16	GO:0004672
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH14 KIFC3 DNAH6 DNAH9	5.85e-06	18	136	4	GO:0008569
GeneOntologyMolecularFunction	protein serine/threonine kinase binding	APP CLTC DNM1 DNM2	1.97e-05	24	136	4	GO:0120283
GeneOntologyMolecularFunction	UDP-glucose:glycoprotein glucosyltransferase activity	UGGT1 UGGT2	4.60e-05	2	136	2	GO:0003980
GeneOntologyMolecularFunction	protein tyrosine kinase activity	NTRK3 ROR1 INSR STYK1 BAZ1B RET SYK	6.16e-05	145	136	7	GO:0004713
GeneOntologyMolecularFunction	UDP-glucosyltransferase activity	POGLUT3 UGGT1 UGGT2	8.41e-05	13	136	3	GO:0035251
GeneOntologyMolecularFunction	PTB domain binding	INSR APP	1.38e-04	3	136	2	GO:0051425
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR1 RYR2	2.74e-04	4	136	2	GO:0005219
GeneOntologyMolecularFunction	glucosyltransferase activity	POGLUT3 UGGT1 UGGT2	4.33e-04	22	136	3	GO:0046527
GeneOntologyMolecularFunction	histone H2AX kinase activity	BAZ1B PRKDC	4.54e-04	5	136	2	GO:0141003
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR1 RYR2	6.78e-04	6	136	2	GO:0048763
GeneOntologyMolecularFunction	histone kinase activity	BAZ1B PRKAA2 PRKDC	8.94e-04	28	136	3	GO:0035173
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH14 DNAH6 DNAH9	8.94e-04	28	136	3	GO:0051959
GeneOntologyMolecularFunction	D2 dopamine receptor binding	DNM1 DNM2	9.46e-04	7	136	2	GO:0031749
GeneOntologyMolecularFunction	clathrin light chain binding	CLTCL1 CLTC	9.46e-04	7	136	2	GO:0032051
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	SMG1 RPS6KB1 ADCK1 MAP3K3 CSNK1G3 PRKAA2 SYK MAST1 PRKDC MAPK10	9.72e-04	446	136	10	GO:0004674
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	NTRK3 ROR1 INSR RET	1.01e-03	65	136	4	GO:0004714
GeneOntologyMolecularFunction	microtubule motor activity	DNAH14 KIFC3 DNAH6 DNAH9	1.33e-03	70	136	4	GO:0003777
GeneOntologyMolecularFunction	RNA polymerase III activity	POLR3A POLR1D	2.00e-03	10	136	2	GO:0001056
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH14 DNAH6 DNAH9	2.03e-03	37	136	3	GO:0045505
GeneOntologyBiologicalProcess	receptor internalization	INSR APP USP6 EGF ATXN2 CLTC SYK DNM1 DNM2	3.20e-06	182	135	9	GO:0031623
GeneOntologyBiologicalProcess	peptidyl-serine modification	SMG1 POGLUT3 HDAC6 NTRK3 RPS6KB1 RET APP CSNK1G3 SYK MAST1 PRKDC	8.31e-06	319	135	11	GO:0018209
GeneOntologyBiologicalProcess	cellular response to ketone	ACACA RPS6KB1 PTGER2 ADCY2 TFAP4 PRKAA2 ASS1	2.38e-05	130	135	7	GO:1901655
GeneOntologyBiologicalProcess	peptidyl-serine phosphorylation	SMG1 HDAC6 NTRK3 RPS6KB1 RET APP CSNK1G3 SYK MAST1 PRKDC	3.52e-05	307	135	10	GO:0018105
GeneOntologyBiologicalProcess	regulation of receptor internalization	INSR APP USP6 EGF ATXN2 SYK	3.79e-05	95	135	6	GO:0002090
GeneOntologyBiologicalProcess	UDP-glucosylation	UGGT1 UGGT2	4.25e-05	2	135	2	GO:0097359
GeneOntologyBiologicalProcess	mitotic cell cycle process	ADAMTS1 RPS6KB1 INSR BAZ1B CUL7 APP RRM2 USH1C TRRAP TFAP4 EGF CLTC NCAPD2 PRKDC USP47 ANAPC4 DNM2	4.35e-05	854	135	17	GO:1903047
GeneOntologyBiologicalProcess	positive regulation of receptor internalization	INSR APP EGF SYK	6.99e-05	34	135	4	GO:0002092
GeneOntologyBiologicalProcess	regulation of receptor-mediated endocytosis	INSR APP USP6 EGF ATXN2 SYK DNM2	7.62e-05	156	135	7	GO:0048259
GeneOntologyBiologicalProcess	receptor-mediated endocytosis	CLTCL1 INSR APP USP6 EGF ATXN2 CLTC SYK DNM1 DNM2	7.69e-05	337	135	10	GO:0006898
GeneOntologyBiologicalProcess	positive regulation of receptor-mediated endocytosis	INSR APP EGF SYK DNM2	7.78e-05	67	135	5	GO:0048260
GeneOntologyBiologicalProcess	mitotic cell cycle	CLTCL1 ADAMTS1 RPS6KB1 INSR BAZ1B CUL7 APP RRM2 USH1C TRRAP TFAP4 EGF CLTC NCAPD2 PRKDC USP47 ANAPC4 DNM2	1.11e-04	1014	135	18	GO:0000278
GeneOntologyBiologicalProcess	vesicle scission	DNM1 DNM2	1.27e-04	3	135	2	GO:0099050
GeneOntologyBiologicalProcess	regulation of cell cycle process	SLF1 ADAMTS1 INSR BAZ1B XPO1 CUL7 APP RRM2 TRRAP TFAP4 EGF CLTC NCAPD2 PRKDC USP47 ANAPC4	1.32e-04	845	135	16	GO:0010564
GeneOntologyBiologicalProcess	cellular response to prostaglandin E stimulus	ACACA PTGER2 PRKAA2	1.44e-04	16	135	3	GO:0071380
GeneOntologyBiologicalProcess	organophosphate metabolic process	GPLD1 CLN8 SMG1 ACACA PARG INSR HKDC1 PLCD4 APP RRM2 SUCLA2 ADCY2 SGPP1 PRKAA2 BSCL2 PIPSL G6PD IPMK ALPL	1.64e-04	1142	135	19	GO:0019637
GeneOntologyCellularComponent	photoreceptor inner segment	HKDC1 USH1C KIFAP3 DNM1 DNM2	1.56e-04	78	136	5	GO:0001917
GeneOntologyCellularComponent	clathrin-coated pit	CLTCL1 APP CLTC DNM1 DNM2	1.76e-04	80	136	5	GO:0005905
GeneOntologyCellularComponent	photoreceptor ribbon synapse	CLTC CTBP2 DNM1	2.05e-04	18	136	3	GO:0098684
Domain	Kinase-like_dom	SMG1 NTRK3 RPS6KB1 ROR1 ADCK1 INSR STYK1 RET TRRAP MAP3K3 CSNK1G3 PRKAA2 SYK MAST1 PRKDC DNM1 MAPK10 DNM2	7.33e-08	542	135	18	IPR011009
Domain	ARM-type_fold	USP34 SMG1 CLTCL1 IPO8 USP24 XPO1 CUL7 TRRAP FMNL2 AP4E1 KIFAP3 CLTC NCAPD2 PRKDC	1.70e-07	339	135	14	IPR016024
Domain	FAT	SMG1 TRRAP PRKDC	7.27e-06	6	135	3	PS51189
Domain	FATC	SMG1 TRRAP PRKDC	7.27e-06	6	135	3	PS51190
Domain	FATC_dom	SMG1 TRRAP PRKDC	7.27e-06	6	135	3	IPR003152
Domain	PIK_FAT	SMG1 TRRAP PRKDC	7.27e-06	6	135	3	IPR014009
Domain	FATC	SMG1 TRRAP PRKDC	7.27e-06	6	135	3	SM01343
Domain	Clathrin	CLTCL1 WDR19 CLTC	1.27e-05	7	135	3	PF00637
Domain	Clathrin_H-chain/VPS_repeat	CLTCL1 WDR19 CLTC	2.01e-05	8	135	3	IPR000547
Domain	PROTEIN_KINASE_ATP	NTRK3 RPS6KB1 ROR1 ADCK1 INSR STYK1 RET MAP3K3 CSNK1G3 PRKAA2 SYK MAST1 MAPK10	2.90e-05	459	135	13	PS00107
Domain	Clathrin_H-chain_propeller_rpt	CLTCL1 CLTC	5.19e-05	2	135	2	IPR022365
Domain	Clathrin-link	CLTCL1 CLTC	5.19e-05	2	135	2	PF09268
Domain	-	CLTCL1 CLTC	5.19e-05	2	135	2	2.130.10.110
Domain	Clathrin_heavy_chain	CLTCL1 CLTC	5.19e-05	2	135	2	IPR016341
Domain	Clathrin_H-chain_propeller_N	CLTCL1 CLTC	5.19e-05	2	135	2	IPR001473
Domain	UDP-g_GGtrans	UGGT1 UGGT2	5.19e-05	2	135	2	IPR009448
Domain	Clathrin_H-chain_link/propller	CLTCL1 CLTC	5.19e-05	2	135	2	IPR016025
Domain	Clathrin_propel	CLTCL1 CLTC	5.19e-05	2	135	2	PF01394
Domain	Clathrin_H-chain_linker_core	CLTCL1 CLTC	5.19e-05	2	135	2	IPR015348
Domain	UDP-g_GGTase	UGGT1 UGGT2	5.19e-05	2	135	2	PF06427
Domain	Prot_kinase_dom	NTRK3 RPS6KB1 ROR1 ADCK1 INSR STYK1 RET MAP3K3 CSNK1G3 PRKAA2 SYK MAST1 MAPK10	5.55e-05	489	135	13	IPR000719
Domain	PROTEIN_KINASE_DOM	NTRK3 RPS6KB1 ROR1 ADCK1 INSR STYK1 RET MAP3K3 CSNK1G3 PRKAA2 SYK MAST1 MAPK10	6.03e-05	493	135	13	PS50011
Domain	PROTEIN_KINASE_TYR	NTRK3 ROR1 INSR STYK1 RET SYK	7.35e-05	97	135	6	PS00109
Domain	Tyr_kinase_AS	NTRK3 ROR1 INSR STYK1 RET SYK	7.35e-05	97	135	6	IPR008266
Domain	Dynein_heavy_chain_D4_dom	DNAH14 DNAH6 DNAH9	1.27e-04	14	135	3	IPR024317
Domain	Dynein_HC_stalk	DNAH14 DNAH6 DNAH9	1.27e-04	14	135	3	IPR024743
Domain	MT	DNAH14 DNAH6 DNAH9	1.27e-04	14	135	3	PF12777
Domain	AAA_8	DNAH14 DNAH6 DNAH9	1.27e-04	14	135	3	PF12780
Domain	ARM-like	SMG1 IPO8 XPO1 CUL7 TRRAP AP4E1 KIFAP3 NCAPD2 PRKDC	1.54e-04	270	135	9	IPR011989
Domain	Clathrin_H-chain_linker	CLTCL1 CLTC	1.55e-04	3	135	2	IPR012331
Domain	Ryanodine_rcpt	RYR1 RYR2	1.55e-04	3	135	2	IPR003032
Domain	Ryanrecept_TM4-6	RYR1 RYR2	1.55e-04	3	135	2	IPR009460
Domain	RyR	RYR1 RYR2	1.55e-04	3	135	2	PF02026
Domain	RR_TM4-6	RYR1 RYR2	1.55e-04	3	135	2	PF06459
Domain	CLH	CLTCL1 CLTC	1.55e-04	3	135	2	SM00299
Domain	Ryan_recept	RYR1 RYR2	1.55e-04	3	135	2	IPR013333
Domain	DHC_fam	DNAH14 DNAH6 DNAH9	1.58e-04	15	135	3	IPR026983
Domain	Dynein_heavy	DNAH14 DNAH6 DNAH9	1.58e-04	15	135	3	PF03028
Domain	Dynein_heavy_dom	DNAH14 DNAH6 DNAH9	1.58e-04	15	135	3	IPR004273
Domain	Ion_trans_dom	TRPC3 RYR1 RYR2 NALCN KCNS1 CACNA1H	1.80e-04	114	135	6	IPR005821
Domain	Ion_trans	TRPC3 RYR1 RYR2 NALCN KCNS1 CACNA1H	1.80e-04	114	135	6	PF00520
Domain	-	SMG1 TRRAP PRKDC	1.93e-04	16	135	3	1.10.1070.11
Domain	PI3Kc	SMG1 TRRAP PRKDC	1.93e-04	16	135	3	SM00146
Domain	-	IPO8 XPO1 CUL7 TRRAP AP4E1 KIFAP3 NCAPD2 PRKDC	2.13e-04	222	135	8	1.25.10.10
Domain	PI3_PI4_kinase	SMG1 TRRAP PRKDC	2.78e-04	18	135	3	PF00454
Domain	PI3_4_KINASE_1	SMG1 TRRAP PRKDC	2.78e-04	18	135	3	PS00915
Domain	PI3_4_KINASE_2	SMG1 TRRAP PRKDC	2.78e-04	18	135	3	PS00916
Domain	PI3/4_kinase_cat_dom	SMG1 TRRAP PRKDC	2.78e-04	18	135	3	IPR000403
Domain	PI3_4_KINASE_3	SMG1 TRRAP PRKDC	2.78e-04	18	135	3	PS50290
Domain	TPR-like_helical_dom	CLTCL1 TRRAP INTS8 WDR19 EIF3L CLTC PRKDC WDTC1	2.96e-04	233	135	8	IPR011990
Domain	Pkinase_Tyr	NTRK3 ROR1 INSR STYK1 RET SYK	3.51e-04	129	135	6	PF07714
Domain	Tyr_kinase_cat_dom	NTRK3 ROR1 INSR RET SYK	4.44e-04	88	135	5	IPR020635
Domain	TyrKc	NTRK3 ROR1 INSR RET SYK	4.44e-04	88	135	5	SM00219
Domain	Ser-Thr/Tyr_kinase_cat_dom	NTRK3 ROR1 INSR STYK1 RET SYK	5.02e-04	138	135	6	IPR001245
Domain	FATC	SMG1 PRKDC	5.11e-04	5	135	2	PF02260
Domain	Dynamin_central	DNM1 DNM2	7.63e-04	6	135	2	IPR000375
Domain	RIH_assoc-dom	RYR1 RYR2	7.63e-04	6	135	2	IPR013662
Domain	GED	DNM1 DNM2	7.63e-04	6	135	2	SM00302
Domain	Dynamin_M	DNM1 DNM2	7.63e-04	6	135	2	PF01031
Domain	GED_dom	DNM1 DNM2	7.63e-04	6	135	2	IPR020850
Domain	Ins145_P3_rec	RYR1 RYR2	7.63e-04	6	135	2	PF08709
Domain	RIH_assoc	RYR1 RYR2	7.63e-04	6	135	2	PF08454
Domain	RIH_dom	RYR1 RYR2	7.63e-04	6	135	2	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR2	7.63e-04	6	135	2	IPR014821
Domain	Ryanodine_recept-rel	RYR1 RYR2	7.63e-04	6	135	2	IPR015925
Domain	GED	DNM1 DNM2	7.63e-04	6	135	2	PS51388
Domain	-	RYR1 RYR2	7.63e-04	6	135	2	1.25.10.30
Domain	FAT	TRRAP PRKDC	7.63e-04	6	135	2	PF02259
Domain	Dynamin_GTPase_CS	DNM1 DNM2	7.63e-04	6	135	2	IPR019762
Domain	PIK-rel_kinase_FAT	TRRAP PRKDC	7.63e-04	6	135	2	IPR003151
Domain	RYDR_ITPR	RYR1 RYR2	7.63e-04	6	135	2	PF01365
Domain	GED	DNM1 DNM2	7.63e-04	6	135	2	PF02212
Domain	GED	DNM1 DNM2	7.63e-04	6	135	2	IPR003130
Domain	-	CLTCL1 TRRAP INTS8 WDR19 EIF3L CLTC WDTC1	7.77e-04	207	135	7	1.25.40.10
Domain	G_DYNAMIN_1	DNM1 DNM2	1.06e-03	7	135	2	PS00410
Domain	ANION_EXCHANGER_2	SLC4A8 SLC4A2	1.06e-03	7	135	2	PS00220
Domain	ANION_EXCHANGER_1	SLC4A8 SLC4A2	1.06e-03	7	135	2	PS00219
Domain	CHCR	CLTCL1 CLTC	1.06e-03	7	135	2	PS50236
Domain	DYNc	DNM1 DNM2	1.06e-03	7	135	2	SM00053
Domain	USP_CS	USP34 USP24 USP6 USP47	1.33e-03	66	135	4	IPR018200
Domain	USP_1	USP34 USP24 USP6 USP47	1.66e-03	70	135	4	PS00972
Domain	UCH	USP34 USP24 USP6 USP47	1.74e-03	71	135	4	PF00443
Domain	USP_2	USP34 USP24 USP6 USP47	1.74e-03	71	135	4	PS00973
Domain	-	SLC4A8 SLC4A2	1.81e-03	9	135	2	3.40.1100.10
Domain	Band3_cytoplasmic_dom	SLC4A8 SLC4A2	1.81e-03	9	135	2	IPR013769
Domain	Band_3_cyto	SLC4A8 SLC4A2	1.81e-03	9	135	2	PF07565
Domain	USP_3	USP34 USP24 USP6 USP47	1.84e-03	72	135	4	PS50235
Domain	USP_dom	USP34 USP24 USP6 USP47	1.84e-03	72	135	4	IPR028889
Domain	Peptidase_C19_UCH	USP34 USP24 USP6 USP47	1.84e-03	72	135	4	IPR001394
Domain	MIR	RYR1 RYR2	2.25e-03	10	135	2	PF02815
Domain	MIR_motif	RYR1 RYR2	2.25e-03	10	135	2	IPR016093
Domain	PTrfase/Anion_transptr	SLC4A8 SLC4A2	2.25e-03	10	135	2	IPR016152
Domain	HCO3_transpt_euk	SLC4A8 SLC4A2	2.25e-03	10	135	2	IPR003020
Domain	MIR	RYR1 RYR2	2.25e-03	10	135	2	PS50919
Domain	MIR	RYR1 RYR2	2.25e-03	10	135	2	SM00472
Domain	HCO3_cotransp	SLC4A8 SLC4A2	2.25e-03	10	135	2	PF00955
Domain	HCO3_transpt_C	SLC4A8 SLC4A2	2.25e-03	10	135	2	IPR011531
Domain	Tyr_kinase_rcpt_2_CS	NTRK3 INSR	2.73e-03	11	135	2	IPR002011
Domain	C8	MUC5B OTOG	3.26e-03	12	135	2	PF08742
Domain	TIL	MUC5B OTOG	3.26e-03	12	135	2	PF01826
Pathway	REACTOME_GAP_JUNCTION_DEGRADATION	CLTCL1 CLTC DNM1 DNM2	2.51e-06	12	122	4	M15243
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	USP34 POGLUT3 MAN2A1 HDAC6 ACACA ADAMTS1 UGGT1 HKDC1 OAS3 TMEM43 XPO1 SUCLA2 SLC30A4 SLC4A2 TSC22D1 ATXN2 GLUD2 CLTC ASS1 UGGT2 KIFC3 DNAH6 G6PD ALPL	2.51e-09	1451	137	24	30550785
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	USP34 SMG1 PPFIBP1 RPS6KB1 ADCK1 INSR RET CUL7 TRRAP MAP3K3 EGF EIF3L PRKAA2 SYK CTBP2 G6PD IPMK ANAPC4 DNM2	3.47e-09	910	137	19	36736316
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ACACA RPS6KB1 INSR TRPS1 LAMA3 SLITRK3 APP SUCLA2 SLC30A4 TRRAP INTS8 TFAP4 DNAH14 TSC22D1 ATXN2 PRKAA2 TOX3 ASS1 MAST1 CTBP2 CACNA1H SEMA6A BSCL2 ARAP1	4.15e-09	1489	137	24	28611215
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP34 HDAC6 ADAMTS1 FAT3 TRPS1 APBA2 BAZ1B OAS3 TSPYL1 CUL7 APP TRRAP FMNL2 KMT5B OSBPL3 ASS1 MRGBP ANAPC4 ALPL WDTC1	1.68e-08	1116	137	20	31753913
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	TPT1 POGLUT3 ATP6AP1 MAN2A1 ACACA PPFIBP1 UGGT1 USP24 TMEM43 XPO1 APP RRM2 TRRAP EIF3L CLTC ASS1 UGGT2 BSCL2 PRKDC G6PD DNM2	4.04e-08	1297	137	21	33545068
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	CORO1C UGGT1 USP24 OAS3 XPO1 TRRAP GLUD2 CLTC PRKDC G6PD DNM2	1.32e-07	344	137	11	30333137
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	USP34 ACACA USP24 CUL7 TRRAP TRMT6 PIPSL USP47 WDTC1	1.79e-07	212	137	9	33853758
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 ACACA UGGT1 USP24 BAZ1B XPO1 CUL7 TRRAP EIF3L CLTC NCAPD2 PRKDC USP47 DNM2	3.35e-07	653	137	14	22586326
Pubmed	Constitutive activated Cdc42-associated kinase (Ack) phosphorylation at arrested endocytic clathrin-coated pits of cells that lack dynamin.	CLTC DNM1 DNM2	5.95e-07	5	137	3	21169560
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	USP34 HDAC6 ADAMTS1 PPFIBP1 CORO1C TRPS1 APBA2 APP FMNL2 INTS8 WDR19 CLTC MAST1 PRKDC KIFC3 DNM1 USP47 ALPL DNM2	7.52e-07	1285	137	19	35914814
Pubmed	A local, periactive zone endocytic machinery at photoreceptor synapses in close vicinity to synaptic ribbons.	CLTC CTBP2 DNM1	1.19e-06	6	137	3	23785143
Pubmed	Molecular components required for resting and stimulated endocytosis of botulinum neurotoxins by glutamatergic and peptidergic neurons.	CLTC DNM1 DNM2	1.19e-06	6	137	3	23640057
Pubmed	A clathrin-dynamin-dependent endocytic pathway for the uptake of HIV-1 by direct T cell-T cell transmission.	CLTC DNM1 DNM2	1.19e-06	6	137	3	18602423
Pubmed	A novel sorting nexin modulates endocytic trafficking and alpha-secretase cleavage of the amyloid precursor protein.	APP DNM1 DNM2	2.07e-06	7	137	3	18353773
Pubmed	A novel dynamin-associating molecule, formin-binding protein 17, induces tubular membrane invaginations and participates in endocytosis.	EGF DNM1 DNM2	2.07e-06	7	137	3	15252009
Pubmed	Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins.	PLXDC1 NTRK3 ROR1 INSR RET APP	3.12e-06	101	137	6	23382219
Pubmed	5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia.	SMG1 IPO8 CLTC DNM2	3.77e-06	27	137	4	23027611
Pubmed	TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma.	XPO1 TRRAP EIF3L CLTC	4.38e-06	28	137	4	29653964
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	PPFIBP1 ATXN2 DNM1 ARAP1 ANAPC4 DNM2	4.61e-06	108	137	6	19531213
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	USP34 HDAC6 IPO8 CORO1C UGGT1 APBA2 XPO1 TSPYL1 TRRAP POLR3A WDR87 EIF3L CLTC CTBP2 PRKDC MRGBP PIPSL ANAPC4	5.44e-06	1335	137	18	29229926
Pubmed	Protein partners of dynamin-1 in the retina.	CLTC DNM1 DNM2	7.03e-06	10	137	3	23746204
Pubmed	Tel2 regulates the stability of PI3K-related protein kinases.	SMG1 TRRAP PRKDC	7.03e-06	10	137	3	18160036
Pubmed	Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions.	HDAC6 RPS6KB1 ROR1 RRM2 PRKDC	9.31e-06	71	137	5	28319113
Pubmed	Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly.	SMG1 TRRAP PRKDC	9.64e-06	11	137	3	20427287
Pubmed	LKB1 deletion causes early changes in atrial channel expression and electrophysiology prior to atrial fibrillation.	ACACA RYR2 PRKAA2 CACNA1H	9.75e-06	34	137	4	26378152
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	CLTCL1 IPO8 UGGT1 XPO1 RRM2 SUCLA2 EIF3L CLTC NCAPD2 CTBP2 PRKDC DNM2	1.04e-05	647	137	12	26618866
Pubmed	Charting the molecular network of the drug target Bcr-Abl.	ACACA CORO1C NCKIPSD CLTC PRKDC DNM1 ARAP1 DNM2	1.13e-05	266	137	8	19380743
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	USP34 TPT1 MED18 TRPS1 BAZ1B XPO1 TRRAP TFAP4 POLR3A EIF3L ASS1 NCAPD2 CTBP2 PRKDC G6PD	1.20e-05	1014	137	15	32416067
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	HDAC6 IPO8 CORO1C INSR HJURP TRPS1 XPO1 EIF3L CLTC ASS1 PRKDC KIFC3 USP47 ARAP1 ANAPC4 WDTC1	1.35e-05	1155	137	16	20360068
Pubmed	Global landscape of HIV-human protein complexes.	UGGT1 TRPS1 TMEM43 XPO1 APP RRM2 SUCLA2 OSBPL3 EIF3L PRKDC	1.44e-05	457	137	10	22190034
Pubmed	Involvement of prostaglandin E2 in production of amyloid-beta peptides both in vitro and in vivo.	APP PTGER2	1.54e-05	2	137	2	17767011
Pubmed	Differential appearance of dynamin in constitutive and regulated exo-endocytosis: a single-cell multiplex RT-PCR study.	DNM1 DNM2	1.54e-05	2	137	2	16028072
Pubmed	Two homologues encoding human UDP-glucose:glycoprotein glucosyltransferase differ in mRNA expression and enzymatic activity.	UGGT1 UGGT2	1.54e-05	2	137	2	10694380
Pubmed	Ryanodine receptor oligomeric interaction: identification of a putative binding region.	RYR1 RYR2	1.54e-05	2	137	2	14722100
Pubmed	Structural and functional interactions within ryanodine receptor.	RYR1 RYR2	1.54e-05	2	137	2	26009179
Pubmed	Dynamin regulates L cell secretion in human gut.	DNM1 DNM2	1.54e-05	2	137	2	34274446
Pubmed	Role of sphingosine-1-phosphate phosphatase 1 in epidermal growth factor-induced chemotaxis.	SGPP1 EGF	1.54e-05	2	137	2	15180992
Pubmed	DNA-PKcs inhibition impairs HDAC6-mediated HSP90 chaperone function on Aurora A and enhances HDACs inhibitor-induced cell killing by increasing mitotic aberrant spindle assembly.	HDAC6 PRKDC	1.54e-05	2	137	2	33404279
Pubmed	Effects of domain composition on catalytic activity of human UDP-glucose:glycoprotein glucosyltransferases.	UGGT1 UGGT2	1.54e-05	2	137	2	27496766
Pubmed	Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion.	RYR1 RYR2	1.54e-05	2	137	2	15033925
Pubmed	An intramolecular signaling element that modulates dynamin function in vitro and in vivo.	DNM1 DNM2	1.54e-05	2	137	2	19515832
Pubmed	Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology.	APBA2 APP	1.54e-05	2	137	2	16906128
Pubmed	Regulation of amyloid beta-protein precursor by phosphorylation and protein interactions.	APBA2 APP	1.54e-05	2	137	2	18650433
Pubmed	Dynamin regulates specific membrane fusion events necessary for acrosomal exocytosis in mouse spermatozoa.	DNM1 DNM2	1.54e-05	2	137	2	22977254
Pubmed	Prostaglandins enhance epidermal growth factor-induced DNA synthesis in hepatocytes by stimulation of E prostanoid 3 and F prostanoid receptors.	PTGER2 EGF	1.54e-05	2	137	2	17567965
Pubmed	Limiting RyR2 Open Time Prevents Alzheimer's Disease-Related Neuronal Hyperactivity and Memory Loss but Not β-Amyloid Accumulation.	APP RYR2	1.54e-05	2	137	2	32966798
Pubmed	Werner protein is a target of DNA-dependent protein kinase in vivo and in vitro, and its catalytic activities are regulated by phosphorylation.	WRN PRKDC	1.54e-05	2	137	2	11889123
Pubmed	Serines 440 and 467 in the Werner syndrome protein are phosphorylated by DNA-PK and affects its dynamics in response to DNA double strand breaks.	WRN PRKDC	1.54e-05	2	137	2	24429382
Pubmed	Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse.	RYR1 ALPL	1.54e-05	2	137	2	17122579
Pubmed	Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damage.	RYR1 ALPL	1.54e-05	2	137	2	22131268
Pubmed	Dynamin at actin tails.	DNM1 DNM2	1.54e-05	2	137	2	11782545
Pubmed	Spatial and Temporal Regulation of Receptor Tyrosine Kinase Activation and Intracellular Signal Transduction.	INSR EGF	1.54e-05	2	137	2	27023845
Pubmed	Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain.	RYR1 RYR2	1.54e-05	2	137	2	25370123
Pubmed	Dynamin 2-dependent endocytosis is essential for mouse oocyte development and fertility.	DNM1 DNM2	1.54e-05	2	137	2	32065700
Pubmed	The noncatalytic portion of human UDP-glucose: glycoprotein glucosyltransferase I confers UDP-glucose binding and transferase function to the catalytic domain.	UGGT1 UGGT2	1.54e-05	2	137	2	12913004
Pubmed	Both isoforms of human UDP-glucose:glycoprotein glucosyltransferase are enzymatically active.	UGGT1 UGGT2	1.54e-05	2	137	2	24415556
Pubmed	Malignant hyperthermia, environmental heat stress, and intracellular calcium dysregulation in a mouse model expressing the p.G2435R variant of RYR1.	RYR1 ALPL	1.54e-05	2	137	2	30236258
Pubmed	Differential curvature sensing and generating activities of dynamin isoforms provide opportunities for tissue-specific regulation.	DNM1 DNM2	1.54e-05	2	137	2	21670293
Pubmed	JNK3 perpetuates metabolic stress induced by Aβ peptides.	APP MAPK10	1.54e-05	2	137	2	22958823
Pubmed	Skeletal and cardiac ryanodine receptors exhibit different responses to Ca2+ overload and luminal ca2+.	RYR1 RYR2	1.54e-05	2	137	2	17259277
Pubmed	Enhanced amyloidogenic metabolism of the amyloid beta-protein precursor in the X11L-deficient mouse brain.	APBA2 APP	1.54e-05	2	137	2	17032642
Pubmed	The neuronal adaptor protein X11beta reduces amyloid beta-protein levels and amyloid plaque formation in the brains of transgenic mice.	APBA2 APP	1.54e-05	2	137	2	15347685
Pubmed	Structure and Function of the Human Ryanodine Receptors and Their Association with Myopathies-Present State, Challenges, and Perspectives.	RYR1 RYR2	1.54e-05	2	137	2	32899693
Pubmed	Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice.	INSR ATXN2	1.54e-05	2	137	2	18250099
Pubmed	Quantitative glycoproteomics reveals cellular substrate selectivity of the ER protein quality control sensors UGGT1 and UGGT2.	UGGT1 UGGT2	1.54e-05	2	137	2	33320095
Pubmed	RNAi-based screening of the human kinome identifies Akt-cooperating kinases: a new approach to designing efficacious multitargeted kinase inhibitors.	CSNK1G3 IPMK	1.54e-05	2	137	2	16247451
Pubmed	X11beta rescues memory and long-term potentiation deficits in Alzheimer's disease APPswe Tg2576 mice.	APBA2 APP	1.54e-05	2	137	2	19744962
Pubmed	Characterization of a second human clathrin heavy chain polypeptide gene (CLH-22) from chromosome 22q11.	CLTCL1 CLTC	1.54e-05	2	137	2	8733129
Pubmed	TRPC3 and NALCN channels drive pacemaking in substantia nigra dopaminergic neurons.	TRPC3 NALCN	1.54e-05	2	137	2	34409942
Pubmed	Interaction between fortilin and transforming growth factor-beta stimulated clone-22 (TSC-22) prevents apoptosis via the destabilization of TSC-22.	TPT1 TSC22D1	1.54e-05	2	137	2	18325344
Pubmed	Senolytics prevent caveolar CaV 3.2-RyR axis malfunction in old vascular smooth muscle.	RYR1 CACNA1H	1.54e-05	2	137	2	37837625
Pubmed	Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma.	NTRK3 RET	1.54e-05	2	137	2	33301751
Pubmed	TRPC3-interacting triadic proteins in skeletal muscle.	TRPC3 RYR1	1.54e-05	2	137	2	18215135
Pubmed	CHC22 and CHC17 clathrins have distinct biochemical properties and display differential regulation and function.	CLTCL1 CLTC	1.54e-05	2	137	2	29097553
Pubmed	Expanding Our Knowledge of Molecular Pathogenesis in Histiocytoses: Solitary Soft Tissue Histiocytomas in Children With a Novel CLTC::SYK Fusion.	CLTC SYK	1.54e-05	2	137	2	37522373
Pubmed	The clathrin heavy chain isoform CHC22 functions in a novel endosomal sorting step.	CLTCL1 CLTC	1.54e-05	2	137	2	20065094
Pubmed	Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway.	INSR APP	1.54e-05	2	137	2	17855343
Pubmed	p70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin's effect on food intake.	RPS6KB1 PRKAA2	1.54e-05	2	137	2	22727014
Pubmed	Recent advances in understanding the ryanodine receptor calcium release channels and their role in calcium signalling.	RYR1 RYR2	1.54e-05	2	137	2	30542613
Pubmed	Dynamin-mediated lipid acquisition is essential for Chlamydia trachomatis development.	DNM1 DNM2	1.54e-05	2	137	2	25116793
Pubmed	Sublethal doses of β-amyloid peptide abrogate DNA-dependent protein kinase activity.	APP PRKDC	1.54e-05	2	137	2	22139836
Pubmed	Functional coupling between TRPC3 and RyR1 regulates the expressions of key triadic proteins.	TRPC3 RYR1	1.54e-05	2	137	2	16484216
Pubmed	Ryanodine receptors are expressed and functionally active in mouse spermatogenic cells and their inhibition interferes with spermatogonial differentiation.	RYR1 RYR2	1.54e-05	2	137	2	15280431
Pubmed	Expression of the ryanodine receptor isoforms in immune cells.	RYR1 RYR2	1.54e-05	2	137	2	11673493
Pubmed	B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators.	RYR1 RYR2	1.54e-05	2	137	2	11673462
Pubmed	Progesterone regulates the expression and activity of two mouse isoforms of the glycoprotein folding sensor UDP-Glc: glycoprotein glucosyltransferase (UGGT).	UGGT1 UGGT2	1.54e-05	2	137	2	24140206
Pubmed	Decrease of dynamin 2 levels in late-onset Alzheimer's disease alters Abeta metabolism.	APP DNM2	1.54e-05	2	137	2	19126407
Pubmed	Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels.	RYR1 RYR2	1.54e-05	2	137	2	18618700
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	ACACA UGGT1 WRN XPO1 CLTC NCAPD2 PRKDC	1.63e-05	202	137	7	33005030
Pubmed	Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.	RPS6KB1 RET APP ADCY2 MAP3K3 EGF PRKAA2 CLTC SYK	1.75e-05	371	137	9	25241761
Pubmed	Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer.	NTRK3 INSR STYK1 RET	1.89e-05	40	137	4	30898150
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	TPT1 CLTCL1 ACACA CORO1C RPS6KB1 UGGT1 MUC5B RYR1 CLTC BSCL2 PRKDC G6PD DNM2	1.96e-05	807	137	13	30575818
Pubmed	The protein tyrosine kinase family of the human genome.	NTRK3 ROR1 INSR RET SYK	2.00e-05	83	137	5	11114734
Pubmed	Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti-aging and metabolic effects of sirtuins.	ACACA WRN LAMA3 NCAPD2	2.08e-05	41	137	4	19343720
Pubmed	Plk2 attachment to NSF induces homeostatic removal of GluA2 during chronic overexcitation.	CLTC DNM1 DNM2	2.11e-05	14	137	3	20802490
Pubmed	Redundant and nonredundant organismal functions of EPS15 and EPS15L1.	CLTC DNM1 DNM2	2.11e-05	14	137	3	30692166
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	USP34 ATP6AP1 IPO8 HJURP BAZ1B TMEM43 XPO1 INTS8 KIFAP3 TSC22D1 ATXN2 EIF3L CLTC NCAPD2 PRKDC ANAPC4	2.22e-05	1203	137	16	29180619
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	HDAC6 ACACA CORO1C BAZ1B OAS3 XPO1 RRM2 TRRAP POLR3A POLR1D EIF3L CLTC ASS1 NCAPD2 CTBP2 PRKDC G6PD	2.49e-05	1353	137	17	29467282
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	CLN8 SMG1 IPO8 PPFIBP1 TMEM43 TSPYL1 TRRAP INTS8 TRMT6 OSBPL3 CSNK1G3 TMEM39A	2.94e-05	719	137	12	35337019
Pubmed	Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis.	KIFAP3 CSNK1G3 SEMA6A	3.23e-05	16	137	3	19451621
Interaction	SHC1 interactions	ACACA CORO1C NTRK3 INSR XPO1 RET APP EGF CLTC NCAPD2 SYK PRKDC ARAP1 DNM2	1.14e-07	362	132	14	int:SHC1
Interaction	TNFSF13B interactions	USP34 IPO8 PPFIBP1 XPO1 APP NCAPD2 TMEM39A PRKDC	1.17e-06	119	132	8	int:TNFSF13B
Interaction	ITGB3 interactions	UGGT1 OAS3 XPO1 APP TRRAP CLTC SYK PRKDC DNM2	1.83e-06	170	132	9	int:ITGB3
Interaction	PIK3R2 interactions	ACACA CORO1C NTRK3 ROR1 INSR STYK1 RET APP EGF SYK	2.86e-06	230	132	10	int:PIK3R2
Interaction	CDC42 interactions	ATP6AP1 HDAC6 ACACA PPFIBP1 CORO1C RPS6KB1 WRN XPO1 TRRAP FMNL2 SLC4A2 SGPP1 POLR1D USP6 CSNK1G3 GLUD2 CLTC NCAPD2 SERPINB2 PRKDC KIFC3 G6PD ARAP1 ALPL	4.74e-06	1323	132	24	int:CDC42
Interaction	NCK1 interactions	NTRK3 NCKIPSD BAZ1B RET TRRAP SYK SEMA6A DNM1 ARAP1 DNM2	4.83e-06	244	132	10	int:NCK1
Interaction	CANX interactions	POGLUT3 ATP6AP1 MAN2A1 HDAC6 CORO1C NTRK3 RPS6KB1 UGGT1 ADCK1 INSR NCKIPSD STYK1 TMEM43 RET CUL7 APP TRRAP SLC4A2 DPEP3 CLTC UGGT2 BSCL2 DNAH9	7.06e-06	1261	132	23	int:CANX
Interaction	FNDC5 interactions	USP34 POGLUT3 MAN2A1 HDAC6 ACACA ADAMTS1 UGGT1 HKDC1 OAS3 MUC5B TMEM43 XPO1 SUCLA2 SLC30A4 SLC4A2 TSC22D1 ATXN2 CLTC ASS1 SERPINB2 UGGT2 KIFC3 DNAH6 G6PD ALPL	8.98e-06	1470	132	25	int:FNDC5
Interaction	PICALM interactions	CLTCL1 HDAC6 NTRK3 ROR1 STYK1 XPO1 FMNL2 POLR1D CLTC DNM2	9.33e-06	263	132	10	int:PICALM
Interaction	PDIA6 interactions	CLN8 SLF1 HDAC6 NTRK3 UGGT1 INSR ATG2B CUL7 APP DPEP3 USP47	1.05e-05	327	132	11	int:PDIA6
Interaction	RUVBL2 interactions	SMG1 CLTCL1 HDAC6 HJURP XPO1 CUL7 APP TRRAP POLR3A POLR1D ASS1 PRKDC MRGBP DNM2 WDTC1	1.27e-05	616	132	15	int:RUVBL2
Interaction	SEC24A interactions	USP34 MAN2A1 NTRK3 TRPC3 ROR1 INSR STYK1 XPO1 RET	1.71e-05	224	132	9	int:SEC24A
Interaction	UNC5B interactions	NTRK3 ROR1 INSR STYK1 RET FMNL2	1.88e-05	84	132	6	int:UNC5B
Interaction	BIN1 interactions	HDAC6 IPO8 APP ATXN2 CLTC DNM1 DNM2	2.27e-05	129	132	7	int:BIN1
Interaction	GAB1 interactions	NTRK3 INSR STYK1 RET FMNL2 MAP3K3 SYK DNM2	2.30e-05	178	132	8	int:GAB1
Interaction	CFD interactions	USP34 POGLUT3 MAN2A1 HDAC6 ACACA ADAMTS1 UGGT1 HKDC1 OAS3 TMEM43 XPO1 SUCLA2 SLC30A4 SLC4A2 TSC22D1 ATXN2 CLTC ASS1 UGGT2 KIFC3 DNAH6 G6PD ALPL	2.38e-05	1360	132	23	int:CFD
Interaction	ERBB2 interactions	ATP6AP1 HDAC6 NTRK3 INSR STYK1 SLITRK3 XPO1 RET APP RRM2 EGF CLTC SYK PRKDC	3.28e-05	589	132	14	int:ERBB2
Interaction	EGLN3 interactions	USP34 IPO8 ACACA UGGT1 PARG HJURP ATG2B USP24 XPO1 TSPYL1 SUCLA2 POLR3A POLR1D ATXN2 WTIP OSBPL3 CTBP2 PRKDC PIPSL G6PD USP47 DNM2	3.47e-05	1296	132	22	int:EGLN3
Interaction	ZNF354C interactions	USP34 HDAC6 IPO8 ASS1	3.68e-05	29	132	4	int:ZNF354C
Interaction	TMEM106B interactions	TPT1 POGLUT3 ATP6AP1 MAN2A1 NTRK3 UGGT1 STYK1 TMEM43 UGGT2 BSCL2	3.72e-05	309	132	10	int:TMEM106B
Interaction	SEC23A interactions	NTRK3 INSR STYK1 XPO1 RET CUL7 SUCLA2 CLTC DNM2	4.73e-05	255	132	9	int:SEC23A
Interaction	PUSL1 interactions	PLCD4 TSPYL1 APP PIPSL WDTC1	4.95e-05	61	132	5	int:PUSL1
Interaction	SELENOF interactions	UGGT1 INSR SERPINB2 UGGT2 WDTC1	5.36e-05	62	132	5	int:SELENOF
Interaction	BAIAP2 interactions	HDAC6 NTRK3 ROR1 NCKIPSD RET APP FMNL2 CSNK1G3	5.45e-05	201	132	8	int:BAIAP2
Interaction	SIK2 interactions	SMG1 CORO1C XPO1 APP FMNL2 ALPL	7.03e-05	106	132	6	int:SIK2
Interaction	EEF2K interactions	CLTCL1 ACACA RPS6KB1 XPO1 PRKAA2	7.25e-05	66	132	5	int:EEF2K
Interaction	HAX1 interactions	NTRK3 INSR ATG2B XPO1 INTS8 POLR3A POLR1D TOX3 CLTC DNM1 MAPK10	7.25e-05	404	132	11	int:HAX1
Interaction	CFTR interactions	POGLUT3 SLC4A8 CLTCL1 HDAC6 IPO8 ACACA ADAMTS1 CORO1C UGGT1 LAMA3 TMEM43 XPO1 RRM2 SUCLA2 RYR2 TSC22D1 CLCNKB EIF3L CLTC NCAPD2 CTBP2 PRKDC DNM2	8.76e-05	1480	132	23	int:CFTR
Interaction	C1QTNF7 interactions	POGLUT3 MAN2A1 ADAMTS1 LAMA3 SEMA6A	8.97e-05	69	132	5	int:C1QTNF7
Interaction	PLK2 interactions	XPO1 APP CLTC DNM1 DNM2	9.61e-05	70	132	5	int:PLK2
Interaction	BIRC5 interactions	MED18 HDAC6 XPO1 MAP3K3 CTBP2 PRKDC	1.05e-04	114	132	6	int:BIRC5
Interaction	SIRT7 interactions	USP34 ACACA UGGT1 USP24 BAZ1B XPO1 CUL7 APP TRRAP EIF3L CLTC NCAPD2 PRKDC USP47 DNM2	1.10e-04	744	132	15	int:SIRT7
Interaction	XRCC1 interactions	PARG XPO1 CUL7 NCAPD2 PRKDC PIPSL TDP1	1.46e-04	173	132	7	int:XRCC1
Interaction	OSBPL5 interactions	CLTCL1 IPO8 APP KIFC3	1.48e-04	41	132	4	int:OSBPL5
Interaction	NUMB interactions	NTRK3 ROR1 XPO1 RET APP FMNL2 UNC5CL CLTC	1.48e-04	232	132	8	int:NUMB
Interaction	DCAF7 interactions	TPT1 PPFIBP1 NCKIPSD XPO1 APP ATXN2 PRKAA2 CLTC MAST1 CTBP2	1.58e-04	368	132	10	int:DCAF7
Interaction	RRM2 interactions	FAT3 RPS6KB1 RET RRM2 PRKDC ANAPC4	1.60e-04	123	132	6	int:RRM2
Interaction	GORASP2 interactions	ATP6AP1 NTRK3 ROR1 STYK1 XPO1 RET APP TSC22D1 TRMT6 KIFC3	1.62e-04	369	132	10	int:GORASP2
Interaction	SEC24B interactions	MAN2A1 NTRK3 TRPC3 INSR STYK1 XPO1 RET CLTC	1.86e-04	240	132	8	int:SEC24B
Interaction	POLR2E interactions	SMG1 MED18 XPO1 CUL7 TRRAP INTS8 POLR3A POLR1D WDTC1	1.99e-04	308	132	9	int:POLR2E
Interaction	CA10 interactions	HKDC1 TSC22D1 ASS1 G6PD	2.32e-04	46	132	4	int:CA10
Interaction	PTK2 interactions	INSR RET APP TRMT6 SERPINB2 SYK DNM1 DNM2 WDTC1	2.35e-04	315	132	9	int:PTK2
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	NTRK3 ROR1 INSR STYK1 RET	1.48e-06	40	89	5	321
GeneFamily	UDP-glucose glycoprotein glucosyltransferases	UGGT1 UGGT2	2.40e-05	2	89	2	440
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR2	7.17e-05	3	89	2	287
GeneFamily	Dyneins, axonemal	DNAH14 DNAH6 DNAH9	7.46e-05	17	89	3	536
GeneFamily	Ubiquitin specific peptidases	USP34 USP24 USP6 USP47	1.66e-04	56	89	4	366
GeneFamily	Cadherin related	FAT3 RET	3.11e-03	17	89	2	24
ToppCell	T_cells-CD56_dim_CD16+_NK_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	ADAMTS1 GRIK4 PTGER2 MEX3C SYK CTBP2 KIFC3 G6PD	1.64e-07	196	136	8	07b557b8530c19ca5b31ad2eac00c36ef1939266
ToppCell	COVID-19-Epithelial-Ionocytes\|Epithelial / Condition, Lineage and Cell class	CLTCL1 MAN2A1 PLXDC1 ADCK1 RET CLCNKB CACNA1H	1.43e-06	181	136	7	4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPFIBP1 TRPC3 TSC22D1 KCNS1 IPMK ALPL CA7	1.72e-06	186	136	7	4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT3 NTRK3 TRPC3 ROR1 PTGER2 RYR2 NALCN	1.91e-06	189	136	7	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRPS1 DNAH14 EGF OSBPL3 PRKAA2 KIFC3 MAPK10	2.43e-06	196	136	7	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	Tracheal\|World / Cell types per location group and 10X technology with lineage, and cell group designations	INSR TRPS1 MUC5B ADCY2 EGF PRKAA2 TOX3	2.78e-06	200	136	7	682960e28542a3d6c119047cd0131941932cfdea
ToppCell	LPS-antiTNF-Unknown-Endothelial-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC4A8 PLXDC1 NTRK3 TRPC3 HJURP RYR2	3.27e-06	132	136	6	02491930097b75aaeedab9e8200711b0dc610944
ToppCell	normal_Pleural_Fluid-B_lymphocytes-Plasma_cells\|normal_Pleural_Fluid / Location, Cell class and cell subclass	MED18 ACACA INSR TFAP4 KIFAP3 WTIP	3.27e-06	132	136	6	4e37400ae7375e6986f060234c373194603346f8
ToppCell	normal_Pleural_Fluid-B_lymphocytes-Plasma_cells\|B_lymphocytes / Location, Cell class and cell subclass	MED18 ACACA INSR TFAP4 KIFAP3 WTIP	7.65e-06	153	136	6	a156710217ef07c07a80ca6504fa0784d86380fa
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	FAT3 GRIK4 ADCY2 RYR1 RYR2 DNAH9	9.53e-06	159	136	6	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPT1 FAT3 RYR2 NALCN DNAH6 DNAH9	1.35e-05	169	136	6	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	PLXDC1 ADAMTS1 NTRK3 TRPC3 RYR2 CACNA1H	1.44e-05	171	136	6	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	USP24 PLCD4 TSC22D1 EGF CLCNKB TOX3	1.54e-05	173	136	6	4bc6d93716f093b460c8b047199db8cab5fea720
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB\|TCGA-Thymus / Sample_Type by Project: Shred V9	NTRK3 ADCY2 RYR1 NALCN CLCNKB KCNS1	1.64e-05	175	136	6	50f9b994bdd389158f92f891944ea81b2fb15eef
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	USP24 PLCD4 TSC22D1 EGF CLCNKB TOX3	1.99e-05	181	136	6	e0abf2707d9e0aa942c657eef7d2cbcd02f060dd
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT3 ROR1 FMNL2 RYR2 NALCN DNM1	2.12e-05	183	136	6	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	USP24 PLCD4 EGF CLCNKB OSBPL3 TOX3	2.12e-05	183	136	6	2e831a4d99c6f983793df71c0994124c943c6da9
ToppCell	COVID-19-Fibroblasts-Pericytes\|COVID-19 / group, cell type (main and fine annotations)	PLXDC1 ADAMTS1 NTRK3 TRPC3 RYR2 CACNA1H	2.25e-05	185	136	6	4905adaeeffd353e089578e5ea614437dbe794e6
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PPFIBP1 INSR USH1C ADCY2 SEMA6A DNM1	2.32e-05	186	136	6	f28d72b47624b69a580b4429e2be560a26898591
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLF1 OAS3 GRIK4 TOX3 EXOC3L1 SEMA6A	2.39e-05	187	136	6	dffa8447c2f3fdacf39a7258c6b4e81a25245041
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	USP24 TSC22D1 EGF CLCNKB OSBPL3 TOX3	2.46e-05	188	136	6	bc089cd73d283ed7d2ecbb3936673b4edc89f666
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	USP24 TSC22D1 EGF CLCNKB OSBPL3 TOX3	2.46e-05	188	136	6	eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 TRPC3 ROR1 RYR2 WTIP KBTBD12	2.54e-05	189	136	6	7fbe855bfdb47d35e040b04a80fe4b729a3764e8
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC4A8 HJURP RET RRM2 ASS1 MAPK10	2.54e-05	189	136	6	815afad947ed77a8b03724bf78014799fed34f54
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 TRPC3 ROR1 RYR2 WTIP KBTBD12	2.54e-05	189	136	6	06b35abecd29f902cf251fcc1f6ad33db7ab08a2
ToppCell	Adult\|World / Lineage, Cell type, age group and donor	HKDC1 EGF KIFC3 ARAP1 ALPL DNM2	2.54e-05	189	136	6	5cd285bfad973125d46d704fec18b21266a63379
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PPFIBP1 APP NALCN PRKAA2 EXOC3L1 SEMA6A	2.61e-05	190	136	6	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PPFIBP1 INSR HKDC1 USH1C KIFC3 DNM1	2.61e-05	190	136	6	989d4eefd22d66ecb857836f8fdbcf41e3047f84
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PPFIBP1 HKDC1 USH1C SEMA6A KIFC3 DNM1	2.69e-05	191	136	6	1cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS1 NTRK3 TRPC3 ROR1 RYR2 WTIP	2.77e-05	192	136	6	bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS1 NTRK3 TRPC3 ROR1 RYR2 WTIP	2.77e-05	192	136	6	b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC4A8 APP EGF OSBPL3 CACNA1H KIFC3	2.77e-05	192	136	6	ee27d27e3d269764dbe8711d0b37ff9331a298a9
ToppCell	Hippocampus-Neuronal\|Hippocampus / BrainAtlas - Mouse McCarroll V32	USP34 TSPYL1 KIFAP3 MAST1 DNM1 MAPK10	2.94e-05	194	136	6	8aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ACACA ROR1 LAMA3 DNAH14 MAPK10 ALPL	2.94e-05	194	136	6	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DNAH14 EGF PRKAA2 TOX3 KIFC3 MAPK10	2.94e-05	194	136	6	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HKDC1 DNAH14 PRKAA2 TOX3 KIFC3 MAPK10	2.94e-05	194	136	6	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	T_cells-CD56_dim_CD16+_NK_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	ADAMTS1 GRIK4 PTGER2 MEX3C CTBP2 G6PD	2.94e-05	194	136	6	335c6c2f3f319d4f19eace62f8826a0f40c130f6
ToppCell	facs-Aorta-Heart-3m-Endothelial\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INSR LAMA3 APP TSC22D1 SEMA6A CA7	3.02e-05	195	136	6	8493f2f60fc356af28b9c0e287d4cd8c8899c081
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ACACA ROR1 LAMA3 DNAH14 MAPK10 ALPL	3.02e-05	195	136	6	9406866f99555198a9be311fbd65751b70f35446
ToppCell	facs-Aorta-Heart-3m-Endothelial-aortic_endothelial_cell\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INSR LAMA3 APP TSC22D1 SEMA6A CA7	3.02e-05	195	136	6	5e5ca7bd94c9e924ed76f7ccac199be745d4c4eb
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	PPFIBP1 INSR APP FMNL2 CTBP2 SEMA6A	3.11e-05	196	136	6	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CLN8 CLTCL1 FAT3 RET USH1C CLCNKB	3.11e-05	196	136	6	72b6a68ee760599ea86cd2d712bfd17b7b4ee417
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS1 NTRK3 TRPC3 RYR2 WTIP CACNA1H	3.20e-05	197	136	6	d1cb30ec4f3024541e9876c70bf63fe4d5c55bf1
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	ROR1 TRPS1 GRIK4 DNAH14 RYR2 MAPK10	3.20e-05	197	136	6	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC4A8 INSR MUC5B ADCY2 PRKAA2 TOX3	3.29e-05	198	136	6	af07a970afaa435c6433bb5c1cbff4c67af350c7
ToppCell	Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC4A8 INSR MUC5B CITED4 PRKAA2 TOX3	3.29e-05	198	136	6	1fe60443c11d34b6d2671af8f06e0dedc8d1558b
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ACACA ROR1 LAMA3 DNAH14 MAPK10 ALPL	3.39e-05	199	136	6	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	ROR1 LAMA3 OSBPL3 UNC5CL KIFC3 DNM2	3.48e-05	200	136	6	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-hematologic-erythrocytic\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	OR4D9 ADCY2 RYR2 WTIP OTOG	4.27e-05	126	136	5	cd02f3d4a3fadd24f3a298639b392f0354d227d2
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-hematologic\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	OR4D9 ADCY2 RYR2 WTIP OTOG	4.27e-05	126	136	5	f2ec5aa6c649ae1ff99519f6897cf207dc292edf
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-hematologic-erythrocytic-erythrocyte\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	OR4D9 ADCY2 RYR2 WTIP OTOG	4.27e-05	126	136	5	61a7e400cbc81691b21cd3c37376c1d19fec2270
ToppCell	Substantia_nigra-Macroglia-CSF_related\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	HKDC1 USH1C DNAH14 UNC5CL DNAH6	6.14e-05	136	136	5	47663c5d81c766a333207a44fc5b58b07309ee76
ToppCell	Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)--\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	HKDC1 USH1C DNAH14 UNC5CL DNAH6	6.14e-05	136	136	5	6d2e5b871f4cf8d64e6fe0be666fb3490797c635
ToppCell	Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	HKDC1 USH1C DNAH14 UNC5CL DNAH6	6.14e-05	136	136	5	fd4269d194c7c11c6ab4383393a01efab05cbace
ToppCell	Substantia_nigra-Macroglia-CSF_related-EPENDYMAL\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	HKDC1 USH1C DNAH14 UNC5CL DNAH6	6.14e-05	136	136	5	3f6cec8d52c84191f7f6e2dd4dc47524dfd5b21b
ToppCell	Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	HKDC1 USH1C DNAH14 UNC5CL DNAH6	6.14e-05	136	136	5	67d736096d6b6ddb4722809557f5e987063b8d23
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ADCK1 ATG2B OAS3	8.37e-05	28	136	3	456cf2e0a6ea59c279efc77a1d02e5572196cb6b
ToppCell	LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CLTCL1 APBA2 SLC30A4 NCAPD2 TDP1	1.10e-04	154	136	5	16fdafb5c64d2db321554f87129a962d113f1668
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|Heart / Disease (COVID-19 only), tissue and cell type	CLTCL1 PLCD4 ADCY2 RYR1 EGF	1.14e-04	155	136	5	d7e26696fd9c0a759524f331243db43059b33ed9
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 MUC5B ADCY2 RYR2 DNAH9	1.32e-04	160	136	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	RV-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	FAT3 NTRK3 LAMA3 WTIP CACNA1H	1.32e-04	160	136	5	29c9b4770d0e73d59cffc7937b179484c76b6dcc
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 MUC5B ADCY2 RYR2 DNAH9	1.32e-04	160	136	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	FAT3 NTRK3 LAMA3 WTIP CACNA1H	1.36e-04	161	136	5	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	Control-Epithelial-Ionocyte\|World / Disease state, Lineage and Cell class	FAT3 ROR1 RET CLCNKB CACNA1H	1.40e-04	162	136	5	e3b9b46ce2faff7d099502df14bbf51e9f183f8c
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5B DNAH14 SERPINB2 DNM1 ALPL	1.48e-04	164	136	5	c5bfae7e9497185548c243d6f9ebadbcef48ba7f
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5B DNAH14 SERPINB2 DNM1 ALPL	1.48e-04	164	136	5	76b0ac220b7ca22fbea28a507f01f96ae9f53932
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5B DNAH14 SERPINB2 DNM1 ALPL	1.48e-04	164	136	5	911081739174ec68bc0893c804e4276b206bea7d
ToppCell	droplet-Lung-nan-21m-Lymphocytic-Proliferating_NK\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTRT3 HJURP RRM2 NCAPD2 MRGBP	1.57e-04	166	136	5	21ba5fd755c0fb31ada42a1b5d60bede0153323d
ToppCell	droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXDC1 NCKIPSD FMNL2 TSC22D1 TOX3	1.80e-04	171	136	5	4e856441063e9825b6f87a1d3dd19c77dae4662c
ToppCell	10x5'-Lung-Lymphocytic_T_CD8-Trm_gut_CD8\|Lung / Manually curated celltypes from each tissue	SLF1 STYK1 HKDC1 ADCY2 TOX3	1.80e-04	171	136	5	c8ccb7795ce8321739e3bc07db2ffc183d04e660
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD8-Tem/emra_CD8\|GI_small-bowel / Manually curated celltypes from each tissue	TPT1 ADCY2 ASS1 SERPINB2 DNAH9	1.80e-04	171	136	5	f28684ea0e74a22f4c140658496068e28a6d3605
ToppCell	facs-Heart-LV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC4A8 PLXDC1 TRPC3 ROR1 OSBPL3	1.90e-04	173	136	5	d78397e65e997ddb995111a810f0e2a4f67d0765
ToppCell	droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	INSR PLCD4 EXOC3L1 SEMA6A ALPL	1.90e-04	173	136	5	66488d01e03264fb193285470901c9c4182fbae8
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HJURP RRM2 USH1C TOX3 DNAH6	1.90e-04	173	136	5	021457c7bdb55de7351e43322d360e8fd7061658
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	INSR MUC5B ADCY2 PRKAA2 TOX3	1.90e-04	173	136	5	464267a2ff3f5c387b6c9c6fa4dab135a221f448
ToppCell	facs-Heart-LV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC4A8 PLXDC1 TRPC3 ROR1 OSBPL3	1.90e-04	173	136	5	3c852ffe22f4a5b632463086b08c669310684e80
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRPC3 TRPS1 STYK1 DNAH14 SEMA6A	1.95e-04	174	136	5	ae363ce736fc8af439f3ad594d7bc2e344db80d4
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DNAH14 EGF CTBP2 DNAH6 ALPL	1.95e-04	174	136	5	2947e5906b172d149412fa4e77476fce4ea695d2
ToppCell	Adult-Epithelial-lung_goblet_cell-D231\|Adult / Lineage, Cell type, age group and donor	INSR MUC5B ADCY2 PRKAA2 TOX3	1.95e-04	174	136	5	7d2f802f493f19a068e097b2909a9000e2160266
ToppCell	10x_5'_v1-Neoplastic-Stem-like-OPC-like\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HJURP RRM2 NALCN TOX3 SEMA6A	2.01e-04	175	136	5	cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9
ToppCell	10x_5'_v1-Neoplastic-Stem-like\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HJURP RRM2 NALCN TOX3 SEMA6A	2.01e-04	175	136	5	a8400e7e47379901dcab5f2e364c3ff17765b4b9
ToppCell	wk_20-22-Hematologic-Myeloid-Promonocyte-like\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	HJURP RRM2 CITED4 NCAPD2 SERPINB2	2.01e-04	175	136	5	654299df246debe0a5b12f0d9568eb828bb94bb9
ToppCell	NS-moderate-d_0-4-Epithelial-Ionocyte\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MAN2A1 ACTRT3 RET CLCNKB ZNF30	2.01e-04	175	136	5	a1e0a15c69211d6db2edeb101476f0f6e08b90c8
ToppCell	droplet-Lung-21m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ACTRT3 HJURP RRM2 NCAPD2 MRGBP	2.01e-04	175	136	5	6751ee4b312d7f87275f2c35e5878cfc3be3ebe3
ToppCell	10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HJURP RRM2 NALCN TOX3 SEMA6A	2.01e-04	175	136	5	8a3abf40146ae3459d97cdf865c1c8f6b92ac639
ToppCell	facs-Skin-nan-24m-Epithelial-basal_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC4A8 TSC22D1 ASS1 SERPINB2 IPMK	2.01e-04	175	136	5	21542be95059983d2c8bdf01ec711fdbf1ec1f62
ToppCell	10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HJURP RRM2 NALCN TOX3 SEMA6A	2.01e-04	175	136	5	378d2b79edac91fc74eee0fb42bb29dd9b07c36f
ToppCell	(9)_Platelet\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	RYR2 TSC22D1 EGF KBTBD12 KIFC3	2.11e-04	177	136	5	0830944c43de300815831a9e2b2fce40965e7d12
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	SMG1 MAN2A1 ACTRT3 TRPC3 UGGT1	2.11e-04	177	136	5	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	(9)_Platelet\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	RYR2 TSC22D1 EGF KBTBD12 KIFC3	2.11e-04	177	136	5	e63d01c7fce4fa1256212fa7e95f74281edb3a01
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	SLC4A8 WRN CUL7 MEX3C GLUD2	2.11e-04	177	136	5	eb0cfe8e9a91910f9979608ed47add48d98ce4dd
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ADCK1 WRN CUL7 POLR3A GLUD2	2.17e-04	178	136	5	9d575902d3dbe33437c9d4200df093a741269803
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	SLC4A8 ADCK1 WRN CUL7 GLUD2	2.17e-04	178	136	5	536a601abcc60867949ea06e9aafb6c7b799b56b
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SMG1 ACACA MEX3C POLR3A NCAPD2	2.17e-04	178	136	5	c87945146b2734141f07b39d268e0d8086ee0364
ToppCell	Adult-Epithelial-lung_goblet_cell\|Adult / Lineage, Cell type, age group and donor	INSR MUC5B ADCY2 PRKAA2 TOX3	2.23e-04	179	136	5	1fc1f252ca943a2f649d1e627f56acbf15f8e058
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLC4A8 MAN2A1 WDR19 WTIP OSBPL3	2.23e-04	179	136	5	adf8b025032a03dbb58871a92025cd7efbeb22ff
ToppCell	TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1\|TCGA-Adrenal / Sample_Type by Project: Shred V9	GPLD1 RET KIFAP3 BSCL2 DNM1	2.23e-04	179	136	5	431e1b29015ec817f778499106d24b19cfc825ae
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLC4A8 USP24 EGF OSBPL3 CACNA1H	2.29e-04	180	136	5	9e09b3dfe344b5d50520711513d389865d73a861
ToppCell	wk_20-22-Hematologic-Meg-ery-Platelet\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CORO1C KIFAP3 EGF KBTBD12 KIFC3	2.34e-04	181	136	5	724efbc200e8388829bc7d81830c2689a95fa838
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	USP24 EGF CLCNKB OSBPL3 TOX3	2.40e-04	182	136	5	5f513bbb7125956eb528e3120de3fd776770a7c3
Drug	myo-inositol	GPLD1 CLTCL1 ACACA TRPC3 INSR PLCD4 PTGER2 TRRAP ADCY2 RYR1 RYR2 EGF CLTC SYK CACNA1H BSCL2 DNM1 MAPK10 IPMK DNM2	6.84e-08	811	135	20	CID000000892
Drug	NSC-364372	CLTCL1 HDAC6 IPO8 RPS6KB1 APBA2 XPO1 RRM2 TRRAP WTIP CSNK1G3 CLTC SERPINB2 CTBP2 MAPK10 DNM2	1.96e-07	484	135	15	CID000435143
Drug	GTP[S]	GPLD1 CLTCL1 MAN2A1 ACTRT3 INSR PLCD4 PTGER2 ADCY2 RYR1 KIFAP3 CLTC CACNA1H BSCL2 DNM1 DNM2	2.39e-06	591	135	15	CID000001764
Drug	AC1OAGFB	GPLD1 CLTCL1 ACTRT3 TRPC3 INSR PLCD4 TRRAP ADCY2 EGF CLTC BSCL2 DNM1 ALPL DNM2	4.07e-06	539	135	14	CID006857345
Drug	glutamate	GPLD1 CLTCL1 ACTRT3 NTRK3 TRPC3 PLCD4 GRIK4 ADCY2 TFAP4 RYR1 RYR2 SLC4A2 CLCNKB GLUD2 ASS1 CACNA1H SEMA6A MAPK10 G6PD	4.13e-06	962	135	19	CID000000611
Drug	library 2	CLTCL1 CLTC DNM1 DNM2	4.28e-06	19	135	4	CID005270634
Drug	A-443654	RPS6KB1 INSR EGF CSNK1G3	5.32e-06	20	135	4	CID010172943
Drug	naphthol AS-BI phosphate	ATP6AP1 APP TRRAP ALPL	7.96e-06	22	135	4	CID000074715
Drug	AC1L1QCE	ATP6AP1 ACACA INSR CLTC	7.96e-06	22	135	4	CID000008135
Drug	Clorocruoro Hem	GPLD1 TRPC3 PLCD4 RET RYR1 RYR2 MAPK10	8.84e-06	123	135	7	CID003518809
Drug	KU55933	CLTCL1 WRN CUL7 CLTC PRKDC	9.49e-06	48	135	5	CID005278396
Drug	ethanol	GPLD1 ATP6AP1 IPO8 NTRK3 RPS6KB1 INSR OAS3 PLCD4 PTGER2 ADCY2 EGF PRKAA2 GLUD2 MAPK10 G6PD ALPL CA7	9.67e-06	837	135	17	CID000000702
Drug	orthovanadate	GPLD1 ATP6AP1 ACTRT3 RPS6KB1 INSR RYR1 EGF SYK MAPK10 DNAH9 G6PD ALPL	1.13e-05	435	135	12	CID000061672
Drug	AC1NST48	GPLD1 ATP6AP1 CLTCL1 MAN2A1 ACTRT3 APP TFAP4 AP4E1 EGF CLTC CTBP2 DNM1 ARAP1 DNM2	1.22e-05	594	135	14	CID005315496
Drug	europium	ACACA INSR WRN RYR1 RYR2 MAP3K3	1.32e-05	87	135	6	CID000023981
Drug	NH4Cl	CLTCL1 APP SLC4A2 EGF GLUD2 CLTC ASS1 CA7	1.44e-05	184	135	8	CID000025517
Drug	Selegiline hydrochloride [14611-52-0]; Up 200; 17.8uM; MCF7; HT_HG-U133A	GPLD1 MED18 PLXDC1 NTRK3 OAS3 RYR2 CACNA1H ARAP1	2.04e-05	193	135	8	4146_UP
Drug	oleoyl-lysophosphatidic acid	GPLD1 CLTCL1 ACTRT3 RPS6KB1 RET SGPP1 EGF CLTC SEMA6A BSCL2 MAPK10	2.22e-05	391	135	11	CID000003987
Drug	ICI 182,780; Down 200; 1uM; PC3; HG-U133A	IPO8 UGGT1 WDR19 ATXN2 BSCL2 MAPK10 ARAP1 CA7	2.36e-05	197	135	8	704_DN
Drug	Betulin [473-98-3]; Up 200; 9uM; MCF7; HT_HG-U133A	CLN8 MED18 HDAC6 IPO8 PLXDC1 APBA2 KCNS1 MAPK10	2.36e-05	197	135	8	3513_UP
Drug	(-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	IPO8 APP ATXN2 SYK CACNA1H SEMA6A ARAP1 WDTC1	2.54e-05	199	135	8	6458_DN
Drug	Spiperone [749-02-0]; Down 200; 10.2uM; HL60; HG-U133A	CLN8 TPT1 CLTCL1 MAN2A1 USP24 ATXN2 PRKDC MAPK10	2.54e-05	199	135	8	1559_DN
Drug	nickel	CLTCL1 ADAMTS1 PLCD4 APP SLC30A4 ADCY2 RYR1 RYR2 CLTC CACNA1H G6PD ALPL CA7	2.56e-05	552	135	13	CID000000934
Drug	etorphine	CLTCL1 ADCY2 CLTC DNM1 DNM2	2.63e-05	59	135	5	CID000026721
Drug	AC1OAGGW	GPLD1 CLTCL1 ACTRT3 INSR PLCD4 CLTC DNM1 DNM2	2.93e-05	203	135	8	CID006857364
Drug	Sulcrate	GPLD1 PLCD4 APP EGF GLUD2 BSCL2 G6PD	2.94e-05	148	135	7	CID006398525
Drug	NSC406942	CLTCL1 ACTRT3 INSR ADCY2 RYR1 RYR2 EGF CSNK1G3 CLTC DNM1 DNAH9 G6PD DNM2	3.26e-05	565	135	13	CID000001115
Drug	DCCD	ATP6AP1 CLTCL1 PTGER2 ADCY2 RYR1 CLTC SEMA6A	3.34e-05	151	135	7	CID000010868
Drug	D-myo-inositol-1,4,5-triphosphate	GPLD1 ACTRT3 TRPC3 PLCD4 PTGER2 ADCY2 RYR1 RYR2 EGF SYK CACNA1H MAPK10 IPMK	3.44e-05	568	135	13	CID000000806
Drug	Badg	CLTCL1 CLTC	3.49e-05	2	135	2	CID000125951
Drug	magnesium	GPLD1 ACTRT3 ADAMTS1 TRPC3 INSR WRN LAMA3 GRIK4 APP RRM2 ADCY2 TFAP4 RYR1 RYR2 CLCNKB CSNK1G3 DNM1 MAPK10 DNAH9 G6PD ALPL	3.50e-05	1325	135	21	CID000000888
Drug	phenylarsine oxide	GPLD1 CLTCL1 ACTRT3 INSR EGF CLTC SYK CACNA1H MAPK10	3.98e-05	275	135	9	CID000004778
Drug	phytate	CLTCL1 ADCY2 CLTC DNM1 IPMK ALPL DNM2	4.65e-05	159	135	7	CID000000890
Drug	2f1b	CLTCL1 MAN2A1 LAMA3 CLTC SYK	4.89e-05	67	135	5	CID011963508
Drug	ST271	GPLD1 PLCD4 EGF SYK	5.37e-05	35	135	4	CID006439072
Drug	glutamic acid diethyl ester	GRIK4 APP TFAP4 GLUD2	6.01e-05	36	135	4	CID000073960
Drug	MIBK	CLTCL1 APP CLTC DNM1 DNM2	6.04e-05	70	135	5	CID000007909
Drug	carbachol	GPLD1 ACTRT3 RPS6KB1 TRPC3 LAMA3 PLCD4 APP ADCY2 RYR1 RYR2 EGF CACNA1H BSCL2 MAPK10	6.09e-05	688	135	14	CID000002551
Drug	NSC381866	ATP6AP1 CLTCL1 MAN2A1 GRIK4 APP CLTC DNM2	6.84e-05	169	135	7	CID000002287
Drug	diaminoguanidine	CLTCL1 CLTC ASS1	7.07e-05	14	135	3	CID000151203
Drug	o-nitrophenyl beta-D-fucopyranoside	CLTCL1 EGF CLTC DNM1 DNM2	7.89e-05	74	135	5	CID000004597
Drug	Fonofos	PLXDC1 ADAMTS1 NTRK3 ROR1 SLITRK3 RET APP PTGER2 ADCY2 RYR2 CITED4 GLUD2 SEMA6A BSCL2	9.04e-05	714	135	14	ctd:D004397
Drug	vanadyl	GPLD1 RPS6KB1 INSR WRN EGF SYK MAPK10 DNAH9 G6PD	9.28e-05	307	135	9	CID000061671
Drug	cis-diammineplatinum(II	RYR1 RYR2	1.04e-04	3	135	2	CID000159790
Drug	2-hydroxyheptanoic acid	RYR1 RYR2	1.04e-04	3	135	2	CID002750949
Drug	8N3-cADPR	RYR1 RYR2	1.04e-04	3	135	2	CID000127713
Drug	aminodantrolene	RYR1 RYR2	1.04e-04	3	135	2	CID009570289
Drug	2-hydroxycarbazole	RYR1 RYR2	1.04e-04	3	135	2	CID000093551
Drug	Ryanodyl 3-(pyridine-3-carboxylate	RYR1 RYR2	1.04e-04	3	135	2	CID005748312
Drug	terbufos	PLXDC1 ADAMTS1 NTRK3 ROR1 SLITRK3 RET APP PTGER2 ADCY2 RYR2 CITED4 GLUD2 SEMA6A BSCL2	1.05e-04	724	135	14	ctd:C012568
Drug	genistein	GPLD1 ACTRT3 RPS6KB1 INSR LAMA3 PLCD4 RET RYR1 RYR2 TSC22D1 EGF CLCNKB NCAPD2 SYK CTBP2 CACNA1H MAPK10 ALPL	1.09e-04	1117	135	18	CID005280961
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A	INSR WRN USP24 RET APP SLC4A2 SYK	1.13e-04	183	135	7	6925_DN
Drug	amiloride	CLTCL1 ACTRT3 RYR1 SLC4A2 EGF CLTC SERPINB2 CACNA1H CA7	1.13e-04	315	135	9	CID000016230
Drug	cobalt-60	GPLD1 LAMA3 GRIK4 SLC30A4 ADCY2 RYR1 RYR2 CLTC CACNA1H CA7	1.14e-04	390	135	10	CID000061492
Drug	aluminum	APP TRRAP ADCY2 GLUD2 BSCL2 G6PD ALPL	1.16e-04	184	135	7	CID000104727
Drug	Arg-pro	CLTCL1 INSR CLTC DNM1 DNM2	1.29e-04	82	135	5	CID000151003
Drug	AC1L1IZE	INSR TFAP4 RYR1 RYR2 MAPK10 DNAH9	1.32e-04	131	135	6	CID000004799
Drug	hydride	ATP6AP1 SLC4A8 MAN2A1 TRPC3 INSR RRM2 RYR1 SLC4A2 EGF GLUD2 CACNA1H SEMA6A G6PD ALPL CA7	1.32e-04	835	135	15	CID000000783
Drug	bicarbonate	ATP6AP1 SLC4A8 ACACA ADCY2 SLC4A2 CLCNKB GLUD2 ALPL CA7	1.43e-04	325	135	9	CID000000767
Drug	Nitrofural [59-87-0]; Down 200; 20.2uM; PC3; HT_HG-U133A	CLN8 MED18 IPO8 MUC5B TRRAP SYK BSCL2	1.47e-04	191	135	7	6721_DN
Drug	GW8510; Up 200; 10uM; MCF7; HT_HG-U133A	OAS3 MUC5B CUL7 APP CACNA1H KIFC3 WDTC1	1.57e-04	193	135	7	7080_UP
Drug	Thiamine hydrochloride [67-03-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A	USP34 MED18 OAS3 CUL7 TFAP4 SEMA6A MAPK10	1.57e-04	193	135	7	2894_DN
Drug	AC1OAGKW	GPLD1 CLTCL1 ACTRT3 RPS6KB1 INSR EGF CLTC	1.57e-04	193	135	7	CID006857413
Drug	Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A	CLN8 MED18 BAZ1B TFAP4 RYR2 AP4E1 WDTC1	1.67e-04	195	135	7	3525_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A	PPFIBP1 NTRK3 UGGT1 ADCY2 TFAP4 OSBPL3 MAPK10	1.67e-04	195	135	7	1785_UP
Drug	Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A	CLN8 PPFIBP1 LAMA3 BAZ1B APP TFAP4 DNM1	1.67e-04	195	135	7	7426_DN
Drug	Halofantrine hydrochloride [36167-63-2]; Up 200; 7.4uM; MCF7; HT_HG-U133A	USP34 IPO8 PPFIBP1 OAS3 KCNS1 SEMA6A WDTC1	1.67e-04	195	135	7	7469_UP
Drug	Dicyclomine hydrochloride [67-92-5]; Down 200; 11.6uM; HL60; HG-U133A	CLN8 USP34 TPT1 MED18 ACACA WRN UGGT2	1.67e-04	195	135	7	1983_DN
Drug	Capsaicin [404-86-4]; Up 200; 13uM; MCF7; HT_HG-U133A	GPLD1 USH1C ADCY2 RYR2 PRKAA2 KCNS1 ARAP1	1.72e-04	196	135	7	3372_UP
Drug	Sulpiride [15676-16-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	USP34 INSR OAS3 MUC5B KCNS1 CACNA1H SEMA6A	1.72e-04	196	135	7	4389_DN
Drug	Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; MCF7; HT_HG-U133A	SLC4A8 IPO8 NCKIPSD STYK1 CUL7 SEMA6A WDTC1	1.72e-04	196	135	7	2834_DN
Drug	Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A	CLN8 USP34 MED18 SLC4A8 BAZ1B ARAP1 WDTC1	1.72e-04	196	135	7	3255_DN
Drug	Beclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; MCF7; HT_HG-U133A	PPFIBP1 APBA2 CUL7 RYR2 KCNS1 CACNA1H ARAP1	1.72e-04	196	135	7	4403_DN
Drug	Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; MCF7; HT_HG-U133A	CLN8 USP24 APBA2 LAMA3 APP WDR19 WDTC1	1.72e-04	196	135	7	5007_DN
Drug	Guanadrel sulfate [22195-34-2]; Down 200; 7.6uM; PC3; HT_HG-U133A	USP34 PPFIBP1 BAZ1B APP ATXN2 SERPINB2 SYK	1.78e-04	197	135	7	7396_DN
Drug	Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A	SLC4A8 STYK1 BAZ1B CUL7 APP ATXN2 WDTC1	1.78e-04	197	135	7	7350_DN
Drug	Josamycin [16846-24-5]; Down 200; 4.8uM; HL60; HG-U133A	CLN8 TPT1 APP KIFAP3 ATXN2 KCNS1 UGGT2	1.78e-04	197	135	7	2034_DN
Drug	Lactobionic acid [96-82-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	MED18 PPFIBP1 BAZ1B SLC4A2 DNM1 ARAP1 WDTC1	1.83e-04	198	135	7	3246_DN
Drug	Norfloxacin [70458-96-7]; Up 200; 12.6uM; PC3; HT_HG-U133A	MED18 TRPC3 ROR1 BAZ1B APP SYK KCNS1	1.83e-04	198	135	7	2090_UP
Drug	Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; MCF7; HT_HG-U133A	HDAC6 PPFIBP1 INSR USP24 STYK1 DNM1 WDTC1	1.83e-04	198	135	7	6261_DN
Drug	Lugol's iodine	ATP6AP1 ACACA SEMA6A	1.84e-04	19	135	3	CID000105053
Drug	SK&F 82958	ADCY2 RYR1 RYR2	1.84e-04	19	135	3	ctd:C071262
Drug	Isopropamide iodide [71-81-8]; Up 200; 8.4uM; PC3; HT_HG-U133A	CLN8 MED18 ROR1 TRPS1 USP24 OSBPL3 ARAP1	1.89e-04	199	135	7	7133_UP
Drug	Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; HL60; HG-U133A	CLN8 USP34 CLTCL1 OAS3 ATXN2 OSBPL3 SYK	1.89e-04	199	135	7	1739_UP
Drug	1,1-dimethylbiguanide hydrochloride; Down 200; 1000uM; MCF7; HG-U133A	TPT1 ACACA NTRK3 INSR OAS3 WDR19 ARAP1	1.89e-04	199	135	7	4_DN
Drug	Leucomisine [17946-87-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A	NTRK3 ADCY2 RYR1 KCNS1 SEMA6A KIFC3 WDTC1	1.89e-04	199	135	7	3546_UP
Drug	Trolox [53188-07-1]; Up 200; 16uM; HL60; HG-U133A	USP34 TPT1 MED18 CLTCL1 WDR19 KCNS1 WDTC1	1.89e-04	199	135	7	1734_UP
Drug	NSC298883	ATP6AP1 CLTCL1 CLTC DNM1 DNM2	1.89e-04	89	135	5	CID000326807
Drug	Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; PC3; HG-U133A	TPT1 ACACA PPFIBP1 TFAP4 SGPP1 SERPINB2 UGGT2	1.95e-04	200	135	7	1952_DN
Drug	aluminum fluoride	GPLD1 CLTCL1 ACTRT3 PLCD4 CLTC BSCL2 DNM1 DNM2	2.03e-04	268	135	8	CID000002124
Drug	2,2'-oxybis(tetrachlorophenol	CLTC G6PD	2.08e-04	4	135	2	CID000087732
Drug	PCB74	RYR1 RYR2	2.08e-04	4	135	2	CID000036218
Drug	AC1OAR8J	CLTCL1 CLTC	2.08e-04	4	135	2	CID006834124
Drug	12-octadecenoic acid	ACACA G6PD	2.08e-04	4	135	2	CID000151512
Drug	O148	ACACA INSR	2.08e-04	4	135	2	CID000078219
Drug	aeroplysinin I	RET EGF	2.08e-04	4	135	2	CID000002036
Drug	2-naphthylbenzothiazole	ACACA INSR	2.08e-04	4	135	2	CID011585872
Drug	Cyclic ADP-Ribose	PARG RYR2	2.08e-04	4	135	2	ctd:D036563
Drug	148504-47-6	RYR1 RYR2	2.08e-04	4	135	2	CID006444275
Drug	SC 38249	RYR1 RYR2	2.08e-04	4	135	2	CID000134834
Disease	hepatic encephalopathy (biomarker_via_orthology)	INSR GLUD2 G6PD	3.92e-05	15	133	3	DOID:13413 (biomarker_via_orthology)
Disease	Gastric Adenocarcinoma	NTRK3 INSR TRRAP PRKAA2	5.09e-05	45	133	4	C0278701
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR2	6.03e-05	3	133	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR2	6.03e-05	3	133	2	DOID:8545 (implicated_via_orthology)
Disease	nt-3 growth factor receptor measurement	NTRK3 ATXN2	6.03e-05	3	133	2	EFO_0020613
Disease	Langer-Giedion Syndrome	TRPS1 MAPK10	6.03e-05	3	133	2	C0023003
Disease	Premature aging syndrome	WRN APP	1.20e-04	4	133	2	C0231341
Disease	centronuclear myopathy 1 (implicated_via_orthology)	DNM1 DNM2	2.00e-04	5	133	2	DOID:0111223 (implicated_via_orthology)
Disease	microcytic anemia (implicated_via_orthology)	DNM1 DNM2	2.00e-04	5	133	2	DOID:11252 (implicated_via_orthology)
Disease	Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology)	DNM1 DNM2	2.00e-04	5	133	2	DOID:0110197 (implicated_via_orthology)
Disease	Gaucher disease	CLN8 NTRK3	2.00e-04	5	133	2	MONDO_0018150
Disease	glucose metabolism disease (implicated_via_orthology)	RPS6KB1 INSR HKDC1	2.70e-04	28	133	3	DOID:4194 (implicated_via_orthology)
Disease	Lennox-Gastaut syndrome	DNM1 MAPK10	2.99e-04	6	133	2	C0238111
Disease	alkaline phosphatase measurement, liver enzyme measurement	GPLD1 ALPL	2.99e-04	6	133	2	EFO_0004533, EFO_0004582
Disease	alcohol dependence (implicated_via_orthology)	RPS6KB1 INSR	7.11e-04	9	133	2	DOID:0050741 (implicated_via_orthology)
Disease	vitamin B6 measurement	OSBPL3 ALPL	8.86e-04	10	133	2	EFO_0004621
Disease	arrhythmogenic right ventricular cardiomyopathy (is_implicated_in)	TMEM43 RYR2	8.86e-04	10	133	2	DOID:0050431 (is_implicated_in)
Disease	Adenocarcinoma of large intestine	ROR1 RET TRRAP PRKDC	9.51e-04	96	133	4	C1319315
Disease	Acute Confusional Senile Dementia	ADAMTS1 INSR APP SLC30A4	1.07e-03	99	133	4	C0546126
Disease	Alzheimer's Disease, Focal Onset	ADAMTS1 INSR APP SLC30A4	1.07e-03	99	133	4	C0750900
Disease	Alzheimer Disease, Early Onset	ADAMTS1 INSR APP SLC30A4	1.07e-03	99	133	4	C0750901
Disease	Presenile dementia	ADAMTS1 INSR APP SLC30A4	1.07e-03	99	133	4	C0011265
Disease	Alzheimer Disease, Late Onset	ADAMTS1 INSR APP SLC30A4	1.07e-03	99	133	4	C0494463
Disease	late onset Parkinson's disease (is_implicated_in)	ATXN2 GLUD2	1.08e-03	11	133	2	DOID:0060892 (is_implicated_in)
Disease	sleep disorder (implicated_via_orthology)	TFAP2E INSR	1.08e-03	11	133	2	DOID:535 (implicated_via_orthology)
Disease	Familial Alzheimer Disease (FAD)	ADAMTS1 INSR APP SLC30A4	1.11e-03	100	133	4	C0276496
Disease	Alzheimer's disease (is_marker_for)	INSR APP EGF ASS1 DNM1 MAPK10	1.12e-03	257	133	6	DOID:10652 (is_marker_for)
Disease	Alzheimer's Disease	ADAMTS1 INSR APP SLC30A4	1.15e-03	101	133	4	C0002395
Disease	PARKINSON DISEASE, LATE-ONSET	ATXN2 GLUD2	1.29e-03	12	133	2	C3160718
Disease	collagen disease (implicated_via_orthology)	DNM1 DNM2	1.29e-03	12	133	2	DOID:854 (implicated_via_orthology)
Disease	prediabetes syndrome (biomarker_via_orthology)	SLC4A8 SLC4A2	1.29e-03	12	133	2	DOID:11716 (biomarker_via_orthology)
Disease	eosinophil measurement	USP34 MED18 TRPS1 ATXN2	1.47e-03	108	133	4	EFO_0803540
Disease	Autosomal Dominant Myotubular Myopathy	RYR1 DNM2	1.52e-03	13	133	2	C3661489
Disease	Centronuclear myopathy	RYR1 DNM2	1.52e-03	13	133	2	C0175709
Disease	X-linked centronuclear myopathy	RYR1 DNM2	1.52e-03	13	133	2	C0410203
Disease	Myopathy, Centronuclear, 1	RYR1 DNM2	1.52e-03	13	133	2	C4551952
Disease	developmental and epileptic encephalopathy (implicated_via_orthology)	DNM1 DNM2	1.52e-03	13	133	2	DOID:0112202 (implicated_via_orthology)
Disease	Congenital Structural Myopathy	RYR1 DNM2	1.52e-03	13	133	2	C0752282
Disease	Myopathy, Centronuclear, Autosomal Dominant	RYR1 DNM2	1.77e-03	14	133	2	C1834558
Disease	Tubular Aggregate Myopathy	RYR1 DNM2	1.77e-03	14	133	2	C0410207
Disease	eating disorder, bipolar disorder	RYR2 NALCN	1.77e-03	14	133	2	EFO_0005203, MONDO_0004985
Disease	Metastatic melanoma	ROR1 MAST1 PRKDC	1.88e-03	54	133	3	C0278883
Disease	Autosomal Recessive Centronuclear Myopathy	RYR1 DNM2	2.04e-03	15	133	2	C3645536
Disease	anemia (implicated_via_orthology)	SLC4A8 SLC4A2	2.04e-03	15	133	2	DOID:2355 (implicated_via_orthology)
Disease	late-onset Alzheimers disease	ADAMTS1 FAT3 APP UNC5CL KIFC3 DNAH6	2.14e-03	292	133	6	EFO_1001870
Disease	Alzheimer's disease (biomarker_via_orthology)	INSR APP DNM1	2.30e-03	58	133	3	DOID:10652 (biomarker_via_orthology)
Disease	plasma protease C1 inhibitor measurement	OR9I1 ATXN2	2.62e-03	17	133	2	EFO_0008261
Disease	pancreatic ductal carcinoma (is_marker_for)	NTRK3 MUC5B EGF	2.66e-03	61	133	3	DOID:3587 (is_marker_for)
Disease	Cardiomyopathies	TMEM43 APP RYR2 PRKAA2	2.89e-03	130	133	4	C0878544
Disease	Congenital Fiber Type Disproportion	RYR1 DNM2	2.94e-03	18	133	2	C0546264
Disease	non-alcoholic fatty liver disease (biomarker_via_orthology)	ACACA INSR G6PD	3.19e-03	65	133	3	DOID:0080208 (biomarker_via_orthology)
Disease	free cholesterol measurement, low density lipoprotein cholesterol measurement	USP24 BAZ1B ATXN2 CSNK1G3	3.49e-03	137	133	4	EFO_0004611, EFO_0008591
Disease	brain measurement, neuroimaging measurement	SLF1 CORO1C FAT3 ROR1 TRPS1 TFAP4 TOX3 CTBP2	3.56e-03	550	133	8	EFO_0004346, EFO_0004464
Disease	HbA1c measurement	ACTRT3 RPS6KB1 BAZ1B HKDC1 EGF ATXN2 MAST1 G6PD ARAP1	3.59e-03	675	133	9	EFO_0004541
Disease	exercise test	WRN RYR2	3.63e-03	20	133	2	EFO_0004328
Disease	Neoplastic Cell Transformation	PARG TSC22D1 EGF CTBP2	3.67e-03	139	133	4	C0007621
Disease	cortical surface area measurement, neuroimaging measurement	SLF1 CORO1C FAT3 ROR1 CTBP2	3.74e-03	227	133	5	EFO_0004346, EFO_0010736
Disease	susceptibility to mononucleosis measurement	ADCY2 RYR2 ANAPC4	3.78e-03	69	133	3	EFO_0008403
Disease	severe acute respiratory syndrome, COVID-19	WRN SUCLA2 POLR1D EIF3L TOX3 CTBP2 ANAPC4	4.24e-03	447	133	7	EFO_0000694, MONDO_0100096

Protein segments in the cluster

Peptide	Gene	Start	Entry
RMYHQTMDVAVLVGD	USH1C	31	Q9Y6N9
ALHVYLGQEMMGSLE	EXOC3L1	341	Q86VI1
NMDYHEIGRSISTLM	SLC4A2	566	P04920
VNEISRHLGKMYSEM	ADCK1	291	Q86TW2
LYVAMLRMTEDHVLP	ANAPC4	421	Q9UJX5
AVGAMMYHTITLTRE	CTBP2	76	P56545
MTHLRVIYERMNQSL	APP	531	P05067
GLDLTNYLMVLMKNH	ACTRT3	181	Q9BYD9
YLNRSVATLLMHMLQ	PRKAA2	236	P54646
ILMTYSVQDHMETRQ	BAZ1B	756	Q9UIG0
LINLDDMHSDMIYNV	CORO1C	166	Q9ULV4
GHMKAVVMDLLRQYL	ACACA	981	Q13085
QETMMDHALRTISYI	APBA2	446	Q99767
NLSRDYVRVMDMGLL	ATG2B	1301	Q96BY7
MDENLMHISYEAGIL	ASS1	181	P00966
MLVHTYSAMERPDGL	TFAP2E	1	Q6VUC0
VMAASLHIYLRMIKE	AP4E1	221	Q9UPM8
SDLYAGMLHSMSRLL	HJURP	261	Q8NCD3
IRYMGIFLVIETHGM	MUC5B	986	Q9HC84
SHRYVETMLVADQSM	ADAMTS1	256	Q9UHI8
HYLGKEMVQNLMVLR	G6PD	201	P11413
DLYVHTMRTLDLLAM	INTS8	211	Q75QN2
LTRVTEFILMGFMDH	OR9I1	6	Q8NGQ6
ITLIRMDSQLHTPMY	OR8I2	46	Q8N0Y5
MRNHTMVTEFILLGI	OR10D4P	1	Q8NGN7
IIASILDSRLHMPMY	OR13C4	46	Q8NGS5
AVIDHMSRIAMYELL	LAMA3	1001	Q16787
VIQMELDHERMSYLL	MAPK10	156	P53779
TMAYLLNRAGLSHML	MAN2A1	296	Q16706
MLHIASQIASGMVYL	NTRK3	656	Q16288
DGRMLHYMTVDDLLS	PPFIBP1	746	Q86W92
TMYPMRIDESIHLQL	EIF3L	376	Q9Y262
IIELVHQVSMGMKYL	SYK	471	P43405
MLLIDIELAYMNTNH	DNM1	476	Q05193
GIYANMRMVHILTSV	ATXN2	261	Q99700
MLLRHGENDFSVMYS	KMT5B	241	Q4FZB7
ELMRDIYSMHIFLTE	PARG	906	Q86W56
MLFAMALERYLSIGH	PTGER2	126	P43116
RVLDLLMHMLSSPDY	CUL7	161	Q14999
TIEYMAPEILMRSGH	RPS6KB1	256	P23443
MLMLLVRGTHYENLR	KCNS1	1	Q96KK3
VVMELMAHGDLKSYL	INSR	1101	P06213
DMLRMYHALKEALNI	DNM2	721	P50570
MIAIQLISRMEYVHS	CSNK1G3	141	Q9Y6M4
MEEIGFLVLGMRVYH	IPMK	171	Q8NFU5
MGLMSLTTNLYEGHI	MAST1	521	Q9Y2H9
KIMDYSLLMSIHNID	PIPSL	266	A2A3N6
INMMEYLLQGSVLDH	MED18	16	Q9BUE0
ISYTVILMMLRSHTG	OR4D9	216	Q8NGE8
YQLMHNIRDIDVIMG	ALPL	206	P05186
MMVALVGYNTILLHT	ADCY2	766	Q08462
VIQFYETMLVRHGVM	DNAH6	1736	Q9C0G6
LLSQQMGMVYALDHD	EGF	506	P01133
LMPMDREHTDLYLLN	FAT3	786	Q8TDW7
LQRGMDLTKREYTMH	FMNL2	906	Q96PY5
AMKIRYLTEQSGHMD	DNAH14	2106	Q0VDD8
HPSMNRLTDALYMVR	CA7	156	P43166
QMHEEFQEMYRLLSG	DNAH9	481	Q9NYC9
EELNRLGMMIDLSYA	DPEP3	256	Q9H4B8
LMLVHSLEYIDLMET	HDAC6	141	Q9UBN7
SLMNYLRMVELEGLT	GRIK4	346	Q16099
SVMLHYRSDLLQMLD	BSCL2	146	Q96G97
MAILVNTLSMGVEYH	CACNA1H	801	O95180
AIMVDSMLHTVYRLS	RYR1	2576	P21817
LAESGIRYTQMPHVM	RYR2	3221	Q92736
IMHTAMKYNLGLDLR	GLUD2	521	P49448
QIAMCVLYHISMDDR	KIFAP3	401	Q92845
RQILEGMSYLHSNMI	MAP3K3	471	Q99759
MSQLLQSMDVLHRTY	OSBPL3	236	Q9H4L5
LMHDSYDVCLVARMN	KBTBD12	591	Q3ZCT8
YSTEDPAMRMHLLGQ	OAS3	676	Q9Y6K5
EHYELRSILRSMGME	SERPINB2	316	P05120
RIEDTGHMYMILTPS	OTOG	2206	Q6ZRI0
LSCMDTYDIEIMIHI	OR8H1	186	Q8NGG4
TDMMPLLHNYVTIDT	IPO8	691	O15397
LLGMLVYRSHLMSSL	MT-ND4L	16	P03901
EEDHTLGNSLRYMIM	POLR1D	46	P0DPB6
MGLNLMTRILYTLVD	TMEM43	321	Q9BTV4
RLLHLMNVEMDQEYA	PLCD4	161	Q9BRC7
LYHMRLSDDTLLDIM	HKDC1	26	Q2TB90
MYESELERAHGQMLE	KIFC3	316	Q9BVG8
LSTMYDMQALHESEI	MRGBP	81	Q9NV56
MTIHCDMVITYGLDQ	SMG1	471	Q96Q15
RCLMKGEYTLESMLH	SMG1	2871	Q96Q15
LFYRGMLDHIGRSLM	SLITRK3	211	O94933
EIEMHIAMRTGNYIE	MEX3C	386	Q5U5Q3
YERRQILHLITMMAL	TENT5D	316	Q8NEK8
CLSRIYMGMHSILDI	SGPP1	246	Q9BX95
IQYTMVNHGMSIDRR	POLR3A	1271	O14802
HVMLLSDLMTYKGEV	POLR3A	1286	O14802
EMATNLMILHSYILV	WDR19	1146	Q8NEZ3
RMLVPENIDTYLIHM	WRN	1336	Q14191
QAMDLVKSHLMYAVR	TSC22D1	986	Q15714
QQYHEIGRSMATIMT	SLC4A8	351	Q2Y0W8
RNLSLHEYMSMELLQ	SUCLA2	51	Q9P2R7
HEYMSMELLQEAGVS	SUCLA2	56	Q9P2R7
FYHTDMMALIDITVR	NCKIPSD	631	Q9NZQ3
LRMEYLSLMHAIVRT	NCKIPSD	656	Q9NZQ3
AMEAMLLYLASRVGD	ARAP1	1261	Q96P48
MADHLMLAEGYRLVQ	CITED4	1	Q96RK1
GHYLAMTTLLLEMST	CLN8	156	Q9UBY8
RAHMGMFTELAILYS	CLTC	1311	Q00610
RAHMGMFTELAILYS	CLTCL1	1311	P53675
ILLDHLDGENYMMRN	NCAPD2	321	Q15021
HLSVMMAAYLGRVRT	CLCNKB	171	P51801
FIGNRTVYMESLHMQ	ROR1	181	Q01973
TVYMESLHMQGEIEN	ROR1	186	Q01973
RDVMTMDGLLYDLTE	STYK1	211	Q6J9G0
YDITHSMLEAMRGVT	POGLUT3	276	Q7Z4H8
DVMLENYRNLVSMGH	ZNF30	41	P17039
GIVFLDEVMYALHMS	TRPS1	1221	Q9UHF7
MMLLLYEEGLRVVIH	TDP1	266	Q9NUW8
EVMLLNMGYRITGLS	WDTC1	641	Q8N5D0
LNLRETLMEALHYML	XPO1	341	O14980
TLMEALHYMLLVSEV	XPO1	346	O14980
IAMENIHSEMYSLLI	RRM2	166	P31350
AMIRGQDAEMLRYIT	TSPYL1	291	Q9H0U9
AASMIHYMVLISARL	TMEM39A	146	Q9NV64
IMIMNGTLYIAARDH	SEMA6A	61	Q9H2E6
MIIYRDLISHDEMFS	TPT1	1	P13693
SHIQFLEMYGEMLAV	GPLD1	211	P80108
DYTTMHRIKLNDRMT	USP47	396	Q96K76
GSLQELHYLMTVMER	UNC5CL	466	Q8IV45
LHYLMTVMERLDCAS	UNC5CL	471	Q8IV45
MSRMILGEYTGLLVN	SLC35E2B	186	P0CK96
TYGLHMILSLKTMDR	ATP6AP1	441	Q15904
YRQDPSLIMRSIVHM	TOX3	146	O15405
VMRHMSDDLGSYVSL	SLF1	641	Q9BQI6
ETGLMYSIMVHALRA	PRKDC	3976	P78527
GMQYLAEMKLVHRDL	RET	861	P07949
NHMRYDTLAQMLTLG	TRMT6	181	Q9UJA5
TIHMNYEINGDIMLI	SLC30A4	206	O14863
HEGIYNMLMLLIELV	USP24	201	Q9UPU5
LIMEMILQALGKSYH	WTIP	296	A6NIX2
AMMLENYRNLHSVDI	ZNF860	51	A6NHJ4
MGDVIHRMLTATQYV	PLXDC1	161	Q8IUK5
RGLILMTESFNTLHM	USP34	2966	Q70CQ2
VASGHLYERFLRIMM	UGGT2	1236	Q9NYU1
LLRSSMHYSLQDMED	WDR87	721	Q6ZQQ6
MLEEQVRSLEAHMYP	TFAP4	171	Q01664
LMMLGDYRSLTLNVV	TRRAP	1431	Q9Y4A5
TGYIIAVHRKMMRTE	USP6	871	P35125
VASGHLYERFLRIMM	UGGT1	1261	Q9NYU2
YEVVHMLLMKGARIE	TRPC3	161	Q13507
LYTAEMIAKMHIRGI	NALCN	81	Q8IZF0